cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA094769 | .a | 711 to 947 | 21 to 252 | tiling clone, | 232/252 (92 %) | 6 diff (97.7 %id) | |||
AA319848 | adrenal gland | .b | 151 to 452 | 1 to 302 | 302/302 (100 %) | 0 diff (100 %id) | |||
AA362221 | .b | 876 to 1192 | 323 to 7 | Submitted on the opposite strand | 317/323 (98 %) | 0 diff (100 %id) | |||
AA365470 | pineal body | .b | 830 to 1070 | 1 to 241 | 241/241 (100 %) | 0 diff (100 %id) | |||
AA383016 | testis | .j | 1199 to 1479 | 1 to 281 | tiling clone, | 281/281 (100 %) | 0 diff (100 %id) | ||
AA385072 | thyroid gland | .g | 584 to 996 | 1 to 413 | 413/428 (96 %) | 3 diff (99.3 %id) | |||
AB445102 | .b | 239 to 955 | 1 to 717 | exact | 717/717 (100 %) | 0 diff (100 %id) | |||
AV701595 | adrenal gland | .i | 813 to 1282 | 1 to 470 | 470/696 (67 %) | 7 diff (99.0 %id) | |||
BP197829 | adrenal gland | .b | 134 to 715 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
DA008760 | adipose | .h | 417 to 981 | 2 to 566 | tiling clone, capped | 565/565 (100 %) | 2 diff (99.7 %id) | ||
AK091425 | brain | .g | 107 to 2857 | 1 to 2754 | S46L | tiling clone, available from FLJ, | 2754/2754 (100 %) | 4 diff (99.9 %id) | |
AK094126 | .i | 534 to 1989 | 631 to 2087 | available from FLJ, | 1457/2087 (69 %) | 6 diff (99.8 %id) | |||
AK297161 | brain | .c | 4 to 1172 | 1 to 1169 | D56G | tiling clone, | 1169/1169 (100 %) | 1 diff (100.0 %id) | |
DA027170 | .b | 135 to 608 | 2 to 475 | capped | 474/474 (100 %) | 0 diff (100 %id) | |||
AW370387 | breast | .g | 221 to 742 | 545 to 24 | 522/545 (95 %) | 1 diff (99.9 %id) | |||
AW578501 | colon | .g | 227 to 703 | 491 to 16 | 476/491 (96 %) | 2 diff (99.6 %id) | |||
BG940187 | blood | .b | 796 to 1194 | 427 to 29 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 399/399 (100 %) | 0 diff (100 %id) | |
AX746975 | .g | 107 to 2857 | 1 to 2754 | S46L | 2754/2754 (100 %) | 4 diff (99.9 %id) | |||
AY166860 | brain | .b | 113 to 1194 | 1 to 1082 | exact | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 1082/1082 (100 %) | 0 diff (100 %id) |
AY513287 | .b | 158 to 2481 | 1 to 2327 | exact | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 2327/2329 (99 %) | 3 diff (99.9 %id) | |
BC000997 | Cervix, carcinoma | .b | 154 to 1194 | 1 to 1041 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 1041/1041 (100 %) | 0 diff (100 %id) |
BC017369 | Skin, melanotic melanoma. | .b | 143 to 1194 | 1 to 1052 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 1052/1052 (100 %) | 0 diff (100 %id) |
BC017908 | Brain, primitive neuroectodermal | .b | 136 to 1192 | 1 to 1057 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 1057/1058 (99 %) | 2 diff (99.9 %id) |
BC022328 | Prostate | .b | 136 to 2485 | 1 to 2353 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 2353/2355 (99 %) | 3 diff (99.9 %id) |
BE085942 | breast | .c | 1070 to 1285 | 225 to 7 | Submitted on the opposite strand | 219/230 (95 %) | 0 diff (100 %id) | ||
BE174301 | head_neck | .b | 607 to 1001 | 398 to 1 | Submitted on the opposite strand | 398/398 (100 %) | 35 diff (91.3 %id) | ||
BE769413 | prostate_tumor | .c | 1458 to 1698 | 245 to 5 | 241/245 (98 %) | 0 diff (100 %id) | |||
BE939780 | uterus_tumor | .i | 333 to 733 | 401 to 2 | 400/401 (99 %) | 0 diff (100 %id) | |||
BF085871 | placenta_normal | .c | 570 to 1001 | 432 to 1 | 432/442 (97 %) | 3 diff (99.4 %id) | |||
BF752310 | breast_normal | .c | 1464 to 2020 | 603 to 34 | Submitted on the opposite strand | 570/606 (94 %) | 0 diff (100 %id) | ||
BF763089 | colon_est | .c | 1665 to 2041 | 374 to 1 | Submitted on the opposite strand | 374/374 (100 %) | 2 diff (99.5 %id) | ||
BF830352 | leiomios | .b | 251 to 535 | 288 to 9 | Submitted on the opposite strand | 280/290 (96 %) | 2 diff (99.4 %id) | ||
BF881152 | lung_tumor | .g | 254 to 770 | 526 to 12 | Submitted on the opposite strand | 515/526 (97 %) | 0 diff (100 %id) | ||
BF912293 | uterus_tumor | .b | 251 to 535 | 288 to 9 | Submitted on the opposite strand | 280/290 (96 %) | 2 diff (99.4 %id) | ||
BG925578 | cartilage | .g | 723 to 1264 | 86 to 627 | 542/559 (96 %) | 6 diff (99.0 %id) | |||
DA040623 | bladder | .g | 56 to 621 | 2 to 572 | capped | 571/571 (100 %) | 5 diff (99.2 %id) | ||
DA044509 | bladder | .i | 60 to 622 | 2 to 565 | G21W A22R G23W K24Q G25R ... | capped | 564/564 (100 %) | 1 diff (99.9 %id) | |
BQ374973 | testis_normal | .c | 1496 to 2020 | 566 to 42 | 525/567 (92 %) | 0 diff (100 %id) | |||
DA059220 | cerebellum | .b | 134 to 681 | 2 to 549 | capped | 548/548 (100 %) | 0 diff (100 %id) | ||
DA060172 | cerebellum | .i | 1287 to 1867 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DA066497 | cerebellum | .b | 135 to 635 | 2 to 502 | capped | 501/501 (100 %) | 0 diff (100 %id) | ||
DA104128 | cerebellum | .i | 57 to 613 | 2 to 563 | G5W R6A Y7G G8T E10G ... | capped | 562/562 (100 %) | 5 diff (99.2 %id) | |
DA124099 | cerebellum | .i | 57 to 614 | 2 to 559 | exact | capped | 558/558 (100 %) | 0 diff (100 %id) | |
DA136376 | alzheimer cortex | .i | 57 to 611 | 2 to 556 | exact | capped | 555/555 (100 %) | 0 diff (100 %id) | |
DA140547 | alzheimer cortex | .g | 56 to 600 | 2 to 546 | capped | 545/545 (100 %) | 0 diff (100 %id) | ||
DA141576 | alzheimer cortex | .b | 137 to 600 | 2 to 465 | capped | 464/464 (100 %) | 0 diff (100 %id) | ||
DA146163 | amygdala | .b | 134 to 692 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA169866 | amygdala | .b | 135 to 685 | 2 to 552 | capped | 551/551 (100 %) | 0 diff (100 %id) | ||
DA175583 | amygdala | .b | 135 to 705 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
DA186333 | amygdala | .i | 57 to 605 | 2 to 550 | exact | capped | 549/549 (100 %) | 0 diff (100 %id) | |
DA200072 | brain | .b | 135 to 683 | 2 to 550 | capped | 549/549 (100 %) | 0 diff (100 %id) | ||
DA201177 | brain | .b | 137 to 699 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DA203010 | brain | .b | 135 to 707 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DA206600 | brain | .b | 135 to 707 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DA208645 | brain | .i | 59 to 592 | 2 to 536 | G21W A22R G23W K24Q G25R ... | capped | 535/535 (100 %) | 1 diff (99.9 %id) | |
DA220716 | brain | .i | 57 to 592 | 2 to 538 | R124P R125A R126K R127K S128K ... | capped | 537/537 (100 %) | 1 diff (99.9 %id) | |
DA238903 | brain | .g | 56 to 634 | 2 to 580 | capped | 579/579 (100 %) | 1 diff (99.9 %id) | ||
DA252669 | caudate nucleus | .b | 135 to 702 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | ||
DA256259 | caudate nucleus | .i | 57 to 626 | 2 to 571 | exact | capped | 570/570 (100 %) | 0 diff (100 %id) | |
DA262046 | caudate nucleus | .i | 5 to 569 | 2 to 567 | exact | capped | 566/566 (100 %) | 2 diff (99.7 %id) | |
DA270011 | caudate nucleus | .b | 135 to 688 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
DA277733 | corpus callosum | .i | 57 to 616 | 2 to 564 | G21W A22P G23L K24A G25K ... | capped | 563/563 (100 %) | 3 diff (99.5 %id) | |
DA279985 | corpus callosum | .g | 56 to 629 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DA282421 | corpus callosum | .g | 58 to 623 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
DA330372 | hippocampus | .i | 57 to 605 | 2 to 550 | exact | capped | 549/550 (99 %) | 1 diff (99.9 %id) | |
DA343209 | substantia nigra | .i | 1 to 563 | 2 to 565 | E10X | tiling clone, capped | 564/564 (100 %) | 3 diff (99.5 %id) | |
DA343880 | substantia nigra | .i | 109 to 671 | 2 to 564 | exact | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |
DA352758 | substantia nigra | .b | 162 to 723 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DA353809 | substantia nigra | .b | 137 to 702 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DA354180 | substantia nigra | .b | 137 to 680 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
DA366139 | subthalamic nucleus | .b | 595 to 1166 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DA375079 | thalamus | .i | 59 to 607 | 2 to 555 | S2V R3A Y4L G5L R6G ... | capped | 554/554 (100 %) | 5 diff (99.1 %id) | |
DA375574 | thalamus | .b | 135 to 713 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
DA382556 | thalamus | .b | 137 to 744 | 2 to 609 | capped | 608/608 (100 %) | 0 diff (100 %id) | ||
DA383023 | thalamus | .g | 56 to 625 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA383741 | thalamus | .i | 57 to 684 | 2 to 629 | exact | capped | 628/628 (100 %) | 0 diff (100 %id) | |
DA388874 | thalamus | .g | 55 to 640 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
DA395190 | thalamus | .i | 57 to 650 | 2 to 595 | exact | capped | 594/595 (99 %) | 1 diff (99.9 %id) | |
BT006745 | .b | 239 to 953 | 1 to 715 | 715/717 (99 %) | 1 diff (99.9 %id) | ||||
F10356 | brain, total brain | .c | 2011 to 2314 | 304 to 2 | 303/304 (99 %) | 0 diff (100 %id) | |||
F13487 | brain, total brain | .c | 896 to 1209 | 1 to 314 | 314/314 (100 %) | 0 diff (100 %id) | |||
Z39139 | brain, total brain | .c | 2160 to 2321 | 162 to 1 | 162/162 (100 %) | 0 diff (100 %id) | |||
Z43032 | brain, total brain | .c | 843 to 1123 | 1 to 280 | 280/280 (100 %) | 1 diff (99.7 %id) | |||
CB269725 | adipose | .c | 1519 to 2015 | 496 to 1 | Submitted on the opposite strand | 496/496 (100 %) | 1 diff (99.8 %id) | ||
CB269831 | adipose | .c | 1482 to 2017 | 536 to 1 | Submitted on the opposite strand | 536/536 (100 %) | 1 diff (99.9 %id) | ||
AV739387 | cord Blood | .c | 574 to 1028 | 1 to 430 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 434/431 (100 %) | 32 diff (92.6 %id) | |
BP208885 | cerebellum | .g | 57 to 640 | 1 to 584 | 584/584 (100 %) | 1 diff (99.9 %id) | |||
BP210045 | cerebellum | .b | 136 to 717 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP212419 | cerebrum | .h | 1 to 582 | 1 to 582 | tiling clone, | 582/582 (100 %) | 1 diff (99.9 %id) | ||
CD685433 | normal nasopharynx | .i | 59 to 623 | 22 to 586 | exact | 565/586 (96 %) | 7 diff (98.9 %id) | ||
CD691484 | normal nasopharynx | .c | 580 to 1205 | 19 to 645 | 627/645 (97 %) | 12 diff (98.2 %id) | |||
DA422350 | cervix | .i | 59 to 619 | 2 to 562 | exact | capped | 561/561 (100 %) | 0 diff (100 %id) | |
BU663637 | blood | .b | 433 to 494 | 1 to 62 | 62/62 (100 %) | 0 diff (100 %id) | |||
BU663651 | blood | .g | 55 to 721 | 9 to 675 | 667/675 (98 %) | 6 diff (99.2 %id) | |||
BU664121 | blood | .g | 1 to 650 | 10 to 659 | tiling clone, | 650/659 (98 %) | 6 diff (99.1 %id) | ||
CN395694 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .k | 743 to 1053 | 1 to 311 | 311/311 (100 %) | 0 diff (100 %id) | |||
CN395695 | embryonic stem cells, DMSO-treated H9 cellline | .i | 76 to 793 | 1 to 719 | exact | 719/719 (100 %) | 1 diff (99.9 %id) | ||
CN395696 | embryonic stem cells, DMSO-treated H9 cellline | .g | 537 to 871 | 1 to 335 | 335/335 (100 %) | 1 diff (99.8 %id) | |||
CN395697 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 99 to 714 | 1 to 616 | exact | 616/616 (100 %) | 0 diff (100 %id) | ||
CN395698 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .h | 688 to 1302 | 1 to 615 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 615/615 (100 %) | 3 diff (99.6 %id) |
CN395700 | embryonic stem cells, DMSO-treated H9 cellline | .i | 59 to 831 | 1 to 773 | exact | 773/773 (100 %) | 3 diff (99.7 %id) | ||
CN420088 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 214 to 613 | 1 to 400 | 400/400 (100 %) | 0 diff (100 %id) | |||
CN420094 | embryonic stem cells, DMSO-treated H9 cellline | .b | 143 to 694 | 1 to 552 | 552/552 (100 %) | 0 diff (100 %id) | |||
CN420095 | embryonic stem cells, DMSO-treated H9 cellline | .b | 164 to 856 | 1 to 692 | 692/692 (100 %) | 2 diff (99.8 %id) | |||
CN420097 | embryonic stem cells, DMSO-treated H9 cellline | .b | 151 to 929 | 1 to 782 | 757/785 (96 %) | 16 diff (98.0 %id) | |||
CN420100 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1 to 725 | 1 to 725 | tiling clone, | 725/725 (100 %) | 4 diff (99.5 %id) | ||
CN420104 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 20 to 762 | 1 to 743 | 743/743 (100 %) | 2 diff (99.8 %id) | |||
CN420105 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 5 to 665 | 1 to 661 | 661/661 (100 %) | 0 diff (100 %id) | |||
CN420106 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 448 to 749 | 1 to 302 | 302/302 (100 %) | 0 diff (100 %id) | |||
CN420108 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 93 to 762 | 1 to 670 | 670/670 (100 %) | 3 diff (99.6 %id) | |||
CN420110 | embryonic stem cells, DMSO-treated H9 cellline | .b | 154 to 651 | 1 to 498 | 498/498 (100 %) | 0 diff (100 %id) | |||
CN420112 | embryonic stem cells, DMSO-treated H9 cellline | .b | 151 to 401 | 1 to 251 | 251/251 (100 %) | 0 diff (100 %id) | |||
CN420114 | embryonic stem cells, DMSO-treated H9 cellline | .b | 154 to 367 | 1 to 214 | 214/214 (100 %) | 0 diff (100 %id) | |||
DA427701 | colon | .i | 59 to 628 | 2 to 571 | exact | capped | 570/571 (99 %) | 1 diff (99.9 %id) | |
DA428574 | colon | .g | 55 to 621 | 2 to 570 | capped | 569/569 (100 %) | 4 diff (99.3 %id) | ||
DA430372 | colon | .g | 55 to 619 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | ||
CR598097 | Placenta Cot 25-normalized | .b | 749 to 2451 | 1 to 1703 | tiling clone, | 1703/1703 (100 %) | 0 diff (100 %id) | ||
CR598891 | Placenta Cot 25-normalized | .b | 153 to 1113 | 1 to 961 | exact | 961/961 (100 %) | 0 diff (100 %id) | ||
CR603929 | neuroblastoma | .b | 143 to 1189 | 1 to 1047 | exact | 1047/1047 (100 %) | 0 diff (100 %id) | ||
CR606408 | fetal brain | .i | 65 to 1967 | 1 to 1903 | exact | tiling clone, | 1903/1903 (100 %) | 0 diff (100 %id) | |
CR611966 | fetal brain | .c | 1126 to 2320 | 1 to 1195 | tiling clone, | 1195/1195 (100 %) | 0 diff (100 %id) | ||
CR741620 | Kidney | .c | 1487 to 1974 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
BX456862 | thymus | .b | 140 to 1048 | 1 to 908 | exact | 908/915 (99 %) | 4 diff (99.6 %id) | ||
AL517632 | brain, neuroblastoma, neuroblastoma cells | .b | 669 to 1184 | 514 to 1 | fully sequenced, | 514/514 (100 %) | 9 diff (98.3 %id) | ||
AL517633 | brain, neuroblastoma, neuroblastoma cells | .b | 143 to 1189 | 1 to 1037 | P234X | fully sequenced, | 1037/1037 (100 %) | 11 diff (99.0 %id) | |
AL535167 | brain, fetal brain | .c | 1700 to 2281 | 582 to 1 | 978/1054 (92 %) | 57 diff (94.6 %id) | |||
AL535168 | brain, fetal brain | .c | 11 to 1136 | 1 to 1125 | N45X D118X | tiling clone, | 1125/1125 (100 %) | 8 diff (99.3 %id) | |
BX412988 | brain, fetal brain | .b | 1608 to 2469 | 880 to 10 | 871/887 (98 %) | 0 diff (100 %id) | |||
BX460369 | brain, fetal brain | .b | 144 to 1016 | 1 to 873 | exact | 873/873 (100 %) | 0 diff (100 %id) | ||
AL537016 | brain, fetal brain | .l | 10 to 900 | 1 to 891 | exact | 891/891 (100 %) | 0 diff (100 %id) | ||
AL566605 | brain, fetal brain | .l | 960 to 1864 | 942 to 1 | 864/942 (91 %) | 22 diff (97.7 %id) | |||
AL537673 | brain, fetal brain | .l | 944 to 1857 | 914 to 1 | 914/914 (100 %) | 2 diff (99.8 %id) | |||
AL537674 | brain, fetal brain | .l | 9 to 907 | 1 to 897 | G66* | tiling clone, | 897/902 (99 %) | 3 diff (99.7 %id) | |
AL540258 | brain, fetal brain | .i | 1041 to 1963 | 921 to 4 | fully sequenced, | 918/921 (99 %) | 2 diff (99.8 %id) | ||
AL540259 | brain, fetal brain | .i | 74 to 1071 | 8 to 994 | exact | fully sequenced, | 987/994 (99 %) | 12 diff (98.8 %id) | |
AL557453 | T cells (Jurkat cell line), T cells from T cell leukemia | .b | 144 to 1025 | 1 to 882 | exact | 882/882 (100 %) | 0 diff (100 %id) | ||
AL547333 | placenta, Placenta Cot 25-normalized | .b | 749 to 1653 | 1 to 907 | fully sequenced, | 907/907 (100 %) | 2 diff (99.8 %id) | ||
AL572307 | placenta, Placenta Cot 25-normalized | .b | 1623 to 2451 | 831 to 1 | fully sequenced, | 831/831 (100 %) | 16 diff (98.1 %id) | ||
BX371824 | Placenta Cot 25-normalized | .i | 979 to 1697 | 723 to 4 | 720/854 (84 %) | 31 diff (96.4 %id) | |||
BX427488 | fetal liver, Liver | .i | 980 to 1945 | 964 to 4 | fully sequenced, | 961/964 (99 %) | 29 diff (97.0 %id) | ||
BX427489 | fetal liver, Liver | .i | 66 to 1010 | 1 to 932 | exact | fully sequenced, | 932/932 (100 %) | 13 diff (98.7 %id) | |
CA389983 | eye, RPE/choroid | .b | 146 to 766 | 1 to 621 | 621/621 (100 %) | 0 diff (100 %id) | |||
CU449542 | epidermis | .g | 381 to 1058 | 19 to 696 | 678/710 (95 %) | 13 diff (98.2 %id) | |||
CU452324 | epidermis | .f | 443 to 767 | 19 to 343 | tiling clone, | 325/343 (94 %) | 9 diff (97.4 %id) | ||
CU455454 | epidermis | .g | 381 to 1058 | 19 to 696 | 678/710 (95 %) | 10 diff (98.6 %id) | |||
CU455522 | epidermis | .g | 381 to 601 | 19 to 239 | 221/239 (92 %) | 10 diff (95.9 %id) | |||
CV023183 | mixed | .b | 239 to 864 | 1 to 625 | 625/627 (99 %) | 3 diff (99.6 %id) | |||
DA464098 | .b | 135 to 718 | 2 to 585 | capped | 584/584 (100 %) | 0 diff (100 %id) | |||
DA464949 | .i | 57 to 619 | 2 to 564 | exact | capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
DA465357 | .b | 135 to 702 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
DA469982 | .b | 135 to 710 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | |||
AL048693 | Kidney | .i | 52 to 620 | 1 to 569 | W41C P47Q G48D F49L A50P ... | 569/570 (99 %) | 15 diff (97.4 %id) | ||
AL048024 | uterus | .b | 795 to 1194 | 1 to 400 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 400/400 (100 %) | 0 diff (100 %id) | |
AL048025 | uterus | .b | 862 to 1195 | 342 to 8 | 335/344 (97 %) | 1 diff (99.8 %id) | |||
AL602292 | human skeletal muscle | .i | 338 to 747 | 1 to 410 | 410/410 (100 %) | 3 diff (99.3 %id) | |||
BX504817 | .m-u | 468 to 1118 | 1 to 651 | exact | tiling clone, | 651/653 (99 %) | 1 diff (99.9 %id) | ||
BX952564 | .c | 799 to 1411 | 1 to 613 | tiling clone, | 613/613 (100 %) | 0 diff (100 %id) | |||
BX956085 | .p-u | 1 to 652 | 1 to 653 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 653/653 (100 %) | 5 diff (99.3 %id) | |
BP226142 | .i | 56 to 637 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | |||
BP227632 | .g | 479 to 1059 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | ||||
DT217065 | brain | .i | 55 to 722 | 1 to 668 | E108D | 668/668 (100 %) | 2 diff (99.8 %id) | ||
DT217248 | brain | .i | 56 to 748 | 1 to 693 | R97G | 693/693 (100 %) | 2 diff (99.8 %id) | ||
DT217985 | brain | .c | 461 to 1126 | 1 to 666 | 666/666 (100 %) | 2 diff (99.7 %id) | |||
DT220849 | brain | .i | 4 to 680 | 1 to 677 | K112X | 677/677 (100 %) | 1 diff (99.9 %id) | ||
DW424037 | Liver | .g | 643 to 916 | 17 to 290 | 274/290 (94 %) | 6 diff (98.0 %id) | |||
DW426954 | Liver | .p-u | 328 to 592 | 16 to 280 | 265/280 (94 %) | 6 diff (97.9 %id) | |||
DW440693 | Liver | .p-u | 328 to 651 | 16 to 339 | exact | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 324/339 (95 %) | 6 diff (98.3 %id) |
EC514749 | Prostate | .c | 879 to 977 | 1 to 99 | 99/99 (100 %) | 0 diff (100 %id) | |||
EH323620 | .g | 601 to 652 | 1 to 52 | 52/52 (100 %) | 0 diff (100 %id) | ||||
DA483289 | brain | .c | 5 to 849 | 2 to 846 | D56G R133X R149M R177X R180X ... | capped | 845/845 (100 %) | 8 diff (99.1 %id) | |
DA495487 | brain | .g | 108 to 670 | 2 to 568 | capped | 567/567 (100 %) | 5 diff (99.2 %id) | ||
DB315610 | brain | .g | 2318 to 2857 | 541 to 1 | tiling clone, | 541/541 (100 %) | 1 diff (99.9 %id) | ||
DA496298 | brain | .g | 56 to 630 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DA510164 | brain | .b | 135 to 691 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DA510227 | brain | .i | 622 to 1186 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
DA515698 | brain | .i | 57 to 605 | 2 to 550 | exact | capped | 549/549 (100 %) | 1 diff (99.9 %id) | |
DA517301 | brain | .b | 135 to 635 | 2 to 502 | capped | 501/501 (100 %) | 0 diff (100 %id) | ||
DA529984 | brain | .i | 57 to 665 | 2 to 610 | exact | capped | 609/609 (100 %) | 0 diff (100 %id) | |
DA530383 | brain | .n | 1 to 544 | 2 to 545 | P15L | tiling clone, capped | 544/545 (99 %) | 2 diff (99.7 %id) | |
DA538622 | Kidney | .b | 135 to 703 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | ||
FN047097 | breast carcinoma | .b | 566 to 623 | 58 to 1 | Submitted on the opposite strand | 58/58 (100 %) | 0 diff (100 %id) | ||
FN056127 | breast carcinoma | .c | 818 to 910 | 92 to 1 | Submitted on the opposite strand | 92/93 (98 %) | 1 diff (99.0 %id) | ||
FN057122 | breast carcinoma | .c | 1850 to 1967 | 1 to 118 | 118/118 (100 %) | 0 diff (100 %id) | |||
FN072785 | breast carcinoma | .c | 1604 to 1709 | 1 to 106 | 106/106 (100 %) | 0 diff (100 %id) | |||
FN073499 | breast carcinoma | .c | 2024 to 2093 | 69 to 1 | Submitted on the opposite strand | 69/69 (100 %) | 1 diff (98.6 %id) | ||
FN073553 | breast carcinoma | .b | 167 to 256 | 90 to 1 | Submitted on the opposite strand | 90/98 (91 %) | 2 diff (98.0 %id) | ||
FN088675 | breast carcinoma | .b | 318 to 376 | 58 to 1 | Submitted on the opposite strand | 58/59 (98 %) | 1 diff (98.4 %id) | ||
FN093584 | breast carcinoma | .b | 811 to 864 | 59 to 7 | Submitted on the opposite strand | 53/59 (89 %) | 1 diff (98.4 %id) | ||
FN099381 | breast carcinoma | .c | 1789 to 1885 | 94 to 1 | Submitted on the opposite strand | 94/94 (100 %) | 3 diff (96.9 %id) | ||
FN104996 | breast carcinoma | .g | 778 to 880 | 1 to 105 | 105/105 (100 %) | 4 diff (96.2 %id) | |||
FN108038 | breast carcinoma | .i | 1398 to 1486 | 90 to 1 | Submitted on the opposite strand | 90/101 (89 %) | 3 diff (97.1 %id) | ||
FN110355 | breast carcinoma | .c | 737 to 805 | 80 to 9 | Submitted on the opposite strand | 72/80 (90 %) | 3 diff (96.3 %id) | ||
FN112773 | breast carcinoma | .k | 632 to 746 | 1 to 116 | 116/116 (100 %) | 4 diff (96.6 %id) | |||
FN118276 | breast carcinoma | .b | 422 to 521 | 101 to 1 | Submitted on the opposite strand | 101/101 (100 %) | 1 diff (99.1 %id) | ||
FN133902 | breast carcinoma | .b | 813 to 913 | 101 to 1 | Submitted on the opposite strand | 101/107 (94 %) | 0 diff (100 %id) | ||
FN145409 | breast carcinoma | .c | 840 to 943 | 1 to 104 | 104/104 (100 %) | 0 diff (100 %id) | |||
FN146500 | breast carcinoma | .c | 1524 to 1643 | 121 to 1 | Submitted on the opposite strand | 121/121 (100 %) | 1 diff (99.2 %id) | ||
FN150895 | breast carcinoma | .c | 1217 to 1317 | 102 to 1 | Submitted on the opposite strand | 102/102 (100 %) | 1 diff (99.1 %id) | ||
FN160181 | breast carcinoma | .c | 1886 to 2003 | 118 to 1 | Submitted on the opposite strand | 118/118 (100 %) | 0 diff (100 %id) | ||
FN168628 | breast carcinoma | .b | 360 to 448 | 98 to 10 | Submitted on the opposite strand | 89/98 (90 %) | 0 diff (100 %id) | ||
GD144634 | .k | 2 to 118 | 117 to 1 | Submitted on the opposite strand | 117/117 (100 %) | 2 diff (98.3 %id) | |||
GD153052 | .i | 1149 to 1274 | 7 to 134 | 128/137 (93 %) | 4 diff (97.1 %id) | ||||
AV649622 | corresponding non cancerous liver tissue | .i | 63 to 716 | 15 to 667 | exact | Submitted on the opposite strand | 653/667 (97 %) | 12 diff (98.3 %id) | |
AV654308 | corresponding non cancerous liver tissue | .i | 76 to 716 | 1 to 641 | exact | Submitted on the opposite strand | 641/641 (100 %) | 2 diff (99.7 %id) | |
AV654548 | corresponding non cancerous liver tissue | .i | 73 to 711 | 1 to 638 | A96V P99A D118E | Submitted on the opposite strand | 638/644 (99 %) | 22 diff (96.6 %id) | |
DB511281 | testis | .i | 815 to 1262 | 1 to 449 | Submitted on the opposite strand | 449/450 (99 %) | 3 diff (99.4 %id) | ||
DB512396 | testis | .c | 615 to 1027 | 2 to 411 | Submitted on the opposite strand | 410/417 (98 %) | 15 diff (96.5 %id) | ||
DB522640 | testis | .c | 582 to 1021 | 1 to 440 | AAA | Submitted on the opposite strand | 440/447 (98 %) | 2 diff (99.6 %id) | |
DB527887 | testis | .b | 737 to 1194 | 1 to 458 | Submitted on the opposite strand | 458/458 (100 %) | 0 diff (100 %id) | ||
DB473919 | hippocampus | .b | 134 to 617 | 1 to 484 | 484/484 (100 %) | 0 diff (100 %id) | |||
DB479885 | hippocampus | .i | 58 to 562 | 1 to 506 | L37F R38K T39N V40C W41M ... | 506/506 (100 %) | 2 diff (99.7 %id) | ||
DB493988 | hypothalamus | .g | 55 to 575 | 1 to 521 | 521/526 (99 %) | 3 diff (99.5 %id) | |||
DB565022 | hypothalamus | .b | 748 to 1194 | 1 to 447 | Submitted on the opposite strand | 447/447 (100 %) | 0 diff (100 %id) | ||
BP386696 | pancreatic islet | .b | 151 to 652 | 502 to 1 | 502/502 (100 %) | 0 diff (100 %id) | |||
DA543373 | .i | 56 to 622 | 2 to 563 | F132I | capped | 562/562 (100 %) | 2 diff (99.7 %id) | ||
DA553781 | .b | 135 to 635 | 2 to 502 | capped | 501/501 (100 %) | 0 diff (100 %id) | |||
BY799416 | eye | .p-u | 43 to 588 | 1 to 546 | 546/546 (100 %) | 0 diff (100 %id) | |||
DA562933 | heart | .b | 134 to 608 | 2 to 476 | capped | 475/475 (100 %) | 0 diff (100 %id) | ||
DA565422 | heart | .g | 56 to 623 | 2 to 571 | capped | 570/570 (100 %) | 4 diff (99.3 %id) | ||
DB355518 | whole embryo, mainly head | .c | 479 to 1034 | 29 to 595 | Submitted on the opposite strand | 567/599 (94 %) | 26 diff (95.7 %id) | ||
AU121169 | whole embryo, mainly body | .b | 137 to 863 | 2 to 728 | capped | 727/775 (93 %) | 1 diff (99.9 %id) | ||
AU147039 | whole embryo, mainly body | .b | 1895 to 2480 | 585 to 1 | 585/585 (100 %) | 8 diff (98.7 %id) | |||
BP241839 | Liver | .f | 1 to 573 | 1 to 573 | tiling clone, | 573/573 (100 %) | 6 diff (99.0 %id) | ||
BP417925 | small intestine | .c | 614 to 1028 | 455 to 29 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 427/427 (100 %) | 14 diff (96.8 %id) | |
BJ989768 | hepatoblastoma | .b | 126 to 725 | 1 to 600 | 600/600 (100 %) | 5 diff (99.2 %id) | |||
BJ989769 | hepatoblastoma | .b | 1921 to 2460 | 540 to 1 | 540/540 (100 %) | 0 diff (100 %id) | |||
BP248427 | Kidney | .i | 689 to 1150 | 1 to 462 | 462/465 (99 %) | 2 diff (99.6 %id) | |||
DA582431 | lung | .i | 57 to 600 | 2 to 546 | G21W A22R G23W K24Q G25R ... | capped | 545/545 (100 %) | 1 diff (99.9 %id) | |
DA583432 | lung | .b | 135 to 681 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
DA584117 | lung | .b | 135 to 737 | 2 to 604 | capped | 603/603 (100 %) | 0 diff (100 %id) | ||
DC358626 | lung | .b | 1 to 535 | 1 to 536 | tiling clone, | 536/536 (100 %) | 1 diff (99.9 %id) | ||
BJ995651 | hepatoblastoma | .j | 1 to 576 | 1 to 576 | exact | tiling clone, | 576/576 (100 %) | 0 diff (100 %id) | |
BJ995652 | hepatoblastoma | .j | 1069 to 1668 | 600 to 1 | tiling clone, | 600/600 (100 %) | 23 diff (96.2 %id) | ||
BP251748 | hippocampus | .i | 618 to 1217 | 1 to 600 | 600/600 (100 %) | 0 diff (100 %id) | |||
BP260839 | small intestine | .i | 58 to 629 | 1 to 572 | R38G | 572/572 (100 %) | 6 diff (99.0 %id) | ||
AV723144 | hypothalamus | .i | 464 to 1162 | 693 to 1 | Submitted on the opposite strand | 693/701 (98 %) | 9 diff (98.8 %id) | ||
R14576 | whole brain | .m-u | 866 to 991 | 1 to 126 | 126/131 (96 %) | 2 diff (98.5 %id) | |||
H12245 | whole brain | .a | 687 to 1100 | 1 to 426 | tiling clone, | Submitted on the opposite strand | 426/426 (100 %) | 14 diff (96.8 %id) | |
H12246 | whole brain | .a | 1565 to 1997 | 450 to 14 | AAA | Submitted on the opposite strand | 437/437 (100 %) | 10 diff (97.8 %id) | |
R16501 | liver and spleen | .k | 638 to 918 | 303 to 10 | Submitted on the opposite strand | 294/303 (97 %) | 0 diff (100 %id) | ||
R16799 | liver and spleen | .k | 1 to 282 | 1 to 291 | tiling clone, | Submitted on the opposite strand | 291/303 (96 %) | 13 diff (95.8 %id) | |
R35082 | placenta | .i | 1257 to 1498 | 1 to 250 | 250/262 (95 %) | 13 diff (95.1 %id) | |||
R35083 | placenta | .i | 1703 to 1989 | 294 to 1 | 294/312 (94 %) | 13 diff (95.9 %id) | |||
H47269 | liver and spleen | .i | 782 to 1264 | 490 to 1 | Submitted on the opposite strand | 490/493 (99 %) | 10 diff (98.0 %id) | ||
H47270 | liver and spleen | .g | 554 to 691 | 1 to 138 | Submitted on the opposite strand | 138/138 (100 %) | 2 diff (98.6 %id) | ||
H54020 | liver and spleen | .g | 554 to 928 | 1 to 386 | Submitted on the opposite strand | 386/386 (100 %) | 16 diff (95.9 %id) | ||
H54177 | liver and spleen | .b | 743 to 1195 | 464 to 1 | Submitted on the opposite strand | 460/472 (97 %) | 14 diff (97.1 %id) | ||
N72346 | liver and spleen | .i | 825 to 1262 | 447 to 1 | Submitted on the opposite strand | 447/449 (99 %) | 17 diff (96.3 %id) | ||
N54572 | liver and spleen | .a | 1577 to 1997 | 424 to 1 | 424/424 (100 %) | 3 diff (99.3 %id) | |||
N54064 | liver and spleen | .g | 554 to 772 | 1 to 221 | Submitted on the opposite strand | 221/221 (100 %) | 2 diff (99.1 %id) | ||
N30025 | melanocyte | .i | 1495 to 1992 | 508 to 1 | tiling clone, | 505/514 (98 %) | 18 diff (96.5 %id) | ||
N36371 | melanocyte | .i | 991 to 1497 | 1 to 521 | 521/526 (99 %) | 18 diff (96.6 %id) | |||
N50345 | multiple sclerosis lesions | .c | 1868 to 2041 | 1 to 174 | 174/174 (100 %) | 0 diff (100 %id) | |||
AA210744 | germinal center B cell | .l | 929 to 1497 | 1 to 575 | tiling clone, | 575/577 (99 %) | 14 diff (97.6 %id) | ||
AA211834 | germinal center B cell | .l | 1607 to 1899 | 293 to 1 | 293/354 (82 %) | 1 diff (99.8 %id) | |||
AA278769 | germinal center B cell | .i | 1543 to 1991 | 449 to 1 | 449/449 (100 %) | 1 diff (99.8 %id) | |||
AA278873 | germinal center B cell | .i | 985 to 1483 | 1 to 499 | 499/499 (100 %) | 0 diff (100 %id) | |||
AA284625 | ovarian tumor, ovary | .k | 2201 to 2508 | 308 to 1 | tiling clone, | 308/308 (100 %) | 0 diff (100 %id) | ||
AA290812 | ovarian tumor, ovary | .k | 918 to 1390 | 1 to 473 | tiling clone, | 473/473 (100 %) | 0 diff (100 %id) | ||
AA420591 | .c | 1548 to 2010 | 463 to 1 | 463/468 (98 %) | 2 diff (99.6 %id) | ||||
AA418813 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 999 to 1263 | 265 to 1 | fully sequenced, | 265/265 (100 %) | 0 diff (100 %id) | ||
AA418938 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 782 to 1029 | 1 to 247 | fully sequenced, | 247/247 (100 %) | 2 diff (99.2 %id) | ||
AA425156 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 1566 to 1991 | 426 to 1 | 426/426 (100 %) | 0 diff (100 %id) | |||
AA430316 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 984 to 1355 | 1 to 372 | 372/372 (100 %) | 0 diff (100 %id) | |||
AA581588 | bulk germ cell seminoma | .j | 1359 to 1745 | 387 to 1 | 387/387 (100 %) | 0 diff (100 %id) | |||
AA587575 | bulk alveolar tumor | .a | 1620 to 1931 | 1 to 313 | 313/313 (100 %) | 3 diff (99.1 %id) | |||
AA492594 | thyroid | .l | 1251 to 1738 | 8 to 496 | 487/496 (98 %) | 8 diff (98.4 %id) | |||
AA541496 | metastatic prostate bone lesion | .p-u | 445 to 658 | 212 to 1 | L3S R20A S21V A22L I24L ... | 212/218 (97 %) | 13 diff (94.1 %id) | ||
AA244152 | .j | 1191 to 1597 | 1 to 425 | 443/425 (104 %) | 56 diff (86.9 %id) | ||||
AA244153 | .j | 1313 to 1745 | 445 to 12 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 434/434 (100 %) | 2 diff (99.6 %id) | ||
AA648142 | Ewing's sarcoma | .a | 1633 to 1998 | 367 to 2 | tiling clone, | 366/367 (99 %) | 0 diff (100 %id) | ||
AA662222 | alveolar rhabdomyosarcoma | .b | 625 to 971 | 371 to 25 | 347/373 (93 %) | 2 diff (99.5 %id) | |||
AA721716 | Ewing's sarcoma | .i | 530 to 994 | 25 to 489 | 465/489 (95 %) | 6 diff (98.8 %id) | |||
AA721763 | Ewing's sarcoma | .i | 531 to 1000 | 1 to 470 | 470/470 (100 %) | 4 diff (99.2 %id) | |||
AA729303 | alveolar rhabdomyosarcoma | .c | 1534 to 2017 | 484 to 1 | 484/484 (100 %) | 0 diff (100 %id) | |||
AA810333 | Ewing's sarcoma | .c | 2106 to 2323 | 219 to 2 | 218/226 (96 %) | 0 diff (100 %id) | |||
AA829236 | germinal center B cell | .i | 869 to 1270 | 405 to 3 | 403/405 (99 %) | 0 diff (100 %id) | |||
AA927525 | pooled germ cell tumors | .b | 815 to 1194 | 394 to 15 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 380/380 (100 %) | 0 diff (100 %id) | |
AA939214 | pooled | .i | 867 to 1267 | 401 to 1 | 401/401 (100 %) | 1 diff (99.8 %id) | |||
AA987842 | Kidney, kidney tumor | .c | 2202 to 2317 | 116 to 1 | 116/116 (100 %) | 0 diff (100 %id) | |||
AA995907 | pooled | .c | 1924 to 2317 | 394 to 1 | 394/394 (100 %) | 0 diff (100 %id) | |||
AI082189 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 694 to 1028 | 335 to 1 | 335/335 (100 %) | 1 diff (99.8 %id) | |||
AI040336 | parathyroid gland, parathyroid tumor | .e | 517 to 1119 | 609 to 7 | tiling clone, | 603/609 (99 %) | 0 diff (100 %id) | ||
AI052525 | .k | 705 to 1215 | 529 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 511/511 (100 %) | 4 diff (99.3 %id) | ||
AI142892 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 1879 to 2318 | 440 to 1 | 440/440 (100 %) | 0 diff (100 %id) | |||
AI049887 | .c | 2107 to 2323 | 219 to 3 | tiling clone, | 217/219 (99 %) | 0 diff (100 %id) | |||
AI144513 | heart | .i | 875 to 1265 | 391 to 1 | 391/391 (100 %) | 4 diff (99.0 %id) | |||
AI151368 | placenta | .k | 808 to 1216 | 417 to 9 | 409/417 (98 %) | 0 diff (100 %id) | |||
AI246709 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 812 to 1266 | 455 to 1 | 455/455 (100 %) | 0 diff (100 %id) | |||
AI242838 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 928 to 1264 | 337 to 1 | 337/337 (100 %) | 2 diff (99.5 %id) | |||
AI270102 | esophagus, squamous cell carcinoma | .c | 1900 to 2023 | 124 to 1 | 124/124 (100 %) | 0 diff (100 %id) | |||
AI422435 | brain, glioblastoma (pooled) | .c | 1849 to 2317 | 469 to 1 | 469/469 (100 %) | 0 diff (100 %id) | |||
AI436178 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 741 to 1188 | 448 to 1 | 448/448 (100 %) | 0 diff (100 %id) | |||
AI492291 | Kidney | .c | 722 to 1026 | 315 to 11 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 305/305 (100 %) | 1 diff (99.7 %id) | |
AI453598 | pooled | .i | 808 to 1262 | 455 to 1 | 455/455 (100 %) | 1 diff (99.8 %id) | |||
AI478492 | Kidney | .c | 620 to 1028 | 409 to 1 | 409/410 (99 %) | 1 diff (99.8 %id) | |||
AI559759 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .i | 1199 to 1263 | 91 to 27 | AAA | 65/65 (100 %) | 0 diff (100 %id) | ||
AI657129 | pooled germ cell tumors | .k | 755 to 1215 | 461 to 1 | 461/461 (100 %) | 0 diff (100 %id) | |||
AI698365 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .b | 860 to 1194 | 335 to 1 | 335/341 (98 %) | 12 diff (96.5 %id) | |||
AI702889 | Kidney | .c | 2025 to 2321 | 297 to 1 | 297/297 (100 %) | 0 diff (100 %id) | |||
AI652551 | pooled germ cell tumors | .e | 553 to 1116 | 580 to 17 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 564/677 (83 %) | 2 diff (99.8 %id) | |
AI926911 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .b | 792 to 1194 | 403 to 1 | 403/407 (99 %) | 0 diff (100 %id) | |||
AI961708 | thymus, pooled | .c | 1910 to 2319 | 412 to 3 | 410/412 (99 %) | 0 diff (100 %id) | |||
AI950617 | lung, two pooled squamous cell carcinomas | .c | 1739 to 2011 | 273 to 1 | 273/273 (100 %) | 0 diff (100 %id) | |||
AW236753 | Kidney | .b | 758 to 1194 | 437 to 1 | 437/437 (100 %) | 0 diff (100 %id) | |||
AW195381 | Kidney | .b | 662 to 1194 | 533 to 1 | 533/533 (100 %) | 0 diff (100 %id) | |||
AW513136 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .c | 552 to 1028 | 477 to 1 | 477/477 (100 %) | 0 diff (100 %id) | |||
AW338776 | adenocarcinoma, Pancreas | .c | 1874 to 2317 | 444 to 1 | 444/444 (100 %) | 0 diff (100 %id) | |||
AW674391 | cervical carcinoma cell line, cervix | .b | 157 to 609 | 1 to 453 | 453/454 (99 %) | 12 diff (97.4 %id) | |||
AW674561 | cervical carcinoma cell line, cervix | .b | 725 to 1194 | 470 to 1 | 470/470 (100 %) | 2 diff (99.6 %id) | |||
AW611553 | Kidney | .b | 637 to 1194 | 558 to 1 | 558/558 (100 %) | 0 diff (100 %id) | |||
BQ027476 | mixed | .c | 1473 to 1802 | 346 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 330/330 (100 %) | 0 diff (100 %id) | |
AW874406 | tumor, uterus | .c | 627 to 1027 | 406 to 6 | 401/406 (98 %) | 0 diff (100 %id) | |||
BE326601 | Kidney | .c | 1874 to 2317 | 444 to 1 | 444/444 (100 %) | 0 diff (100 %id) | |||
BE502074 | malignant melanoma, metastatic to lymphnode, skin | .j | 1282 to 1745 | 464 to 1 | tiling clone, | 464/464 (100 %) | 0 diff (100 %id) | ||
BE327978 | malignant melanoma, metastatic to lymphnode, skin | .c | 516 to 1028 | 513 to 1 | 513/513 (100 %) | 0 diff (100 %id) | |||
BE327665 | carcinoid, lung | .i | 810 to 1263 | 454 to 1 | 454/454 (100 %) | 0 diff (100 %id) | |||
BE503285 | pooled germ cell tumors | .b | 650 to 1194 | 545 to 1 | 545/545 (100 %) | 0 diff (100 %id) | |||
BE551041 | carcinoid, lung | .c | 540 to 1029 | 497 to 8 | 490/497 (98 %) | 0 diff (100 %id) | |||
BF438716 | brain, glioblastoma (pooled) | .c | 645 to 1022 | 378 to 1 | 378/378 (100 %) | 0 diff (100 %id) | |||
BE670440 | carcinoid, lung | .c | 570 to 1028 | 472 to 14 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 459/459 (100 %) | 1 diff (99.8 %id) | |
BE671492 | carcinoid, lung | .c | 565 to 1029 | 467 to 3 | 465/467 (99 %) | 0 diff (100 %id) | |||
BE858509 | brain, glioblastoma (pooled) | .c | 488 to 1029 | 544 to 2 | 543/544 (99 %) | 0 diff (100 %id) | |||
BG150249 | carcinoid, lung | .c | 1630 to 2013 | 384 to 1 | 384/384 (100 %) | 0 diff (100 %id) | |||
BF221592 | pooled germ cell tumors | .b | 739 to 1194 | 456 to 1 | 456/456 (100 %) | 0 diff (100 %id) | |||
BE379815 | bladder, carcinoma, cell line | .b | 594 to 1118 | 524 to 1 | fully sequenced, | 524/524 (100 %) | 2 diff (99.7 %id) | ||
BE379909 | bladder, carcinoma, cell line | .b | 155 to 655 | 1 to 504 | fully sequenced, | 504/504 (100 %) | 3 diff (99.5 %id) | ||
BF111096 | carcinoid, lung | .c | 1600 to 2013 | 414 to 1 | 414/414 (100 %) | 0 diff (100 %id) | |||
BE567407 | bladder, carcinoma, cell line | .g | 74 to 653 | 1 to 582 | 582/863 (67 %) | 25 diff (97.2 %id) | |||
BF033354 | adenocarcinoma, ovary | .c | 367 to 1023 | 1 to 657 | 657/657 (100 %) | 11 diff (98.4 %id) | |||
BE908069 | epithelioid carcinoma, Pancreas | .b | 174 to 900 | 1 to 729 | 729/779 (93 %) | 9 diff (98.9 %id) | |||
BF132849 | lung, mucoepidermoid carcinoma | .g | 823 to 1468 | 1 to 644 | G35D R36E R37G S38Q R39G ... | 644/756 (85 %) | 12 diff (98.5 %id) | ||
BG037074 | testis | .g | 50 to 800 | 1 to 739 | 739/744 (99 %) | 30 diff (96.0 %id) | |||
BG036894 | brain, hippocampus | .i | 53 to 803 | 1 to 745 | G16V N17T L18W G19E T20L ... | 745/857 (86 %) | 42 diff (95.1 %id) | ||
BG400661 | Kidney | .g | 56 to 866 | 1 to 802 | 802/804 (99 %) | 22 diff (97.3 %id) | |||
BG400704 | Kidney | .i | 57 to 706 | 1 to 646 | F91L D92I R93D P94H P95L ... | 646/646 (100 %) | 5 diff (99.3 %id) | ||
BG527504 | lung, mucoepidermoid carcinoma | .n | 262 to 1016 | 1 to 759 | tiling clone, | 759/894 (84 %) | 14 diff (98.5 %id) | ||
BG541616 | lung | .i | 57 to 571 | 1 to 515 | exact | 515/516 (99 %) | 2 diff (99.7 %id) | ||
BG562404 | Liver | .i | 57 to 775 | 1 to 721 | F91X | 721/724 (99 %) | 14 diff (98.1 %id) | ||
BG570128 | lung | .g | 56 to 798 | 1 to 748 | 748/753 (99 %) | 20 diff (97.4 %id) | |||
BG706926 | brain, hypothalamus | .g | 50 to 827 | 1 to 782 | 782/787 (99 %) | 29 diff (96.4 %id) | |||
BG702005 | brain, hippocampus | .g | 50 to 732 | 1 to 680 | 680/681 (99 %) | 16 diff (97.7 %id) | |||
BG704531 | brain, hippocampus | .i | 56 to 701 | 8 to 652 | exact | 645/656 (98 %) | 10 diff (98.5 %id) | ||
BG773453 | testis | .i | 51 to 785 | 1 to 733 | exact | 733/733 (100 %) | 7 diff (99.1 %id) | ||
BG771872 | testis | .i | 51 to 567 | 1 to 517 | P95A | 517/517 (100 %) | 7 diff (98.7 %id) | ||
BI517332 | pooled colon, kidney, stomach | .i | 76 to 810 | 1 to 737 | exact | 737/737 (100 %) | 2 diff (99.8 %id) | ||
BI517951 | pooled colon, kidney, stomach | .i | 1265 to 1915 | 693 to 28 | 666/839 (79 %) | 25 diff (97.1 %id) | |||
BI489827 | pooled brain, lung, testis | .i | 66 to 888 | 1 to 824 | exact | 824/824 (100 %) | 9 diff (99.0 %id) | ||
BI464681 | testis | .g | 52 to 830 | 1 to 773 | 773/774 (99 %) | 21 diff (97.3 %id) | |||
BI462673 | testis | .g | 52 to 870 | 1 to 826 | 826/854 (96 %) | 60 diff (93.0 %id) | |||
BI548686 | brain, hippocampus | .g | 52 to 795 | 1 to 746 | 746/747 (99 %) | 7 diff (99.1 %id) | |||
BI458171 | brain, hypothalamus | .g | 52 to 819 | 1 to 762 | 762/763 (99 %) | 12 diff (98.5 %id) | |||
BI562632 | testis | .c | 1 to 745 | 1 to 751 | 751/751 (100 %) | 18 diff (97.7 %id) | |||
BI601554 | brain, hypothalamus | .g | 52 to 1018 | 1 to 962 | 962/999 (96 %) | 47 diff (95.3 %id) | |||
BI670329 | brain, hypothalamus | .g | 50 to 782 | 1 to 732 | 732/733 (99 %) | 8 diff (99.0 %id) | |||
BI669307 | brain, hypothalamus | .b | 131 to 1035 | 1 to 908 | E55* | 908/910 (99 %) | 19 diff (98.0 %id) | ||
BM013599 | breast, mammary adenocarcinoma, cell line | .g | 75 to 721 | 1 to 686 | 683/906 (75 %) | 37 diff (96.0 %id) | |||
BM013604 | breast, mammary adenocarcinoma, cell line | .b | 154 to 973 | 1 to 826 | R220K S221K R222S S223F S225H ... | 824/826 (99 %) | 9 diff (99.0 %id) | ||
BM010170 | amelanotic melanoma, cell line, skin | .c | 15 to 878 | 1 to 888 | E28R R29T A30G F31L Y33V ... | 888/893 (99 %) | 26 diff (97.1 %id) | ||
BM560024 | amelanotic melanoma, cell line, skin | .b | 142 to 1135 | 20 to 1026 | S221K R222S S223F S225F G226R ... | 1005/1122 (89 %) | 38 diff (96.7 %id) | ||
BM454283 | lymph, lymphoma, cell line | .b | 168 to 1036 | 1 to 880 | R201Q M237L | 880/1035 (85 %) | 25 diff (97.6 %id) | ||
BM474545 | leiomyosarcoma, uterus | .d | 1 to 957 | 1 to 966 | G210X | tiling clone, | 966/1002 (96 %) | 22 diff (97.9 %id) | |
BM452957 | melanotic melanoma, skin | .b | 165 to 856 | 1 to 693 | 693/950 (72 %) | 11 diff (98.9 %id) | |||
BM453494 | leiomyosarcoma, uterus | .b | 151 to 864 | 1 to 719 | 719/968 (74 %) | 14 diff (98.6 %id) | |||
BM549066 | melanotic melanoma, skin | .b | 149 to 1050 | 1 to 914 | R210P S211I S213V R214Q S215I ... | 914/1085 (84 %) | 19 diff (98.3 %id) | ||
BM023177 | Islets of Langerhans, Pancreas | .c | 464 to 1027 | 566 to 3 | fully sequenced, | 564/566 (99 %) | 0 diff (100 %id) | ||
BM023459 | Islets of Langerhans, Pancreas | .c | 41 to 525 | 1 to 485 | fully sequenced, | 485/485 (100 %) | 3 diff (99.4 %id) | ||
BM551220 | duodenal adenocarcinoma, cell line, small intestine | .c | 21 to 795 | 13 to 790 | S208K S209Q R210S S211F S213I ... | 778/1080 (72 %) | 13 diff (98.8 %id) | ||
BQ218596 | leiomyosarcoma, uterus | .b | 156 to 1181 | 1 to 1034 | S223F G226X | 1034/1037 (99 %) | 32 diff (97.0 %id) | ||
BM997151 | Chondrosarcoma, Left Pubic Bone | .i | 580 to 1263 | 701 to 19 | AAA | 683/683 (100 %) | 4 diff (99.5 %id) | ||
CB215346 | normal endometrium, late proliferativephase, cycle day 13, uterus | .b | 151 to 795 | 1 to 645 | 645/645 (100 %) | 0 diff (100 %id) | |||
BQ218171 | epithelioid carcinoma, Pancreas | .g | 74 to 908 | 12 to 848 | 837/849 (98 %) | 12 diff (98.6 %id) | |||
BQ549855 | insulinoma, Pancreas | .i | 1125 to 1527 | 7 to 409 | fully sequenced, | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 403/409 (98 %) | 0 diff (100 %id) | |
BQ613990 | insulinoma, Pancreas | .i | 1466 to 1991 | 542 to 17 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 526/526 (100 %) | 0 diff (100 %id) | |
BQ231934 | melanotic melanoma, skin | .b | 148 to 1010 | 1 to 863 | exact | 863/867 (99 %) | 2 diff (99.8 %id) | ||
CK826483 | Pancreas, Purified pancreatic islet | .c | 1824 to 2317 | 510 to 16 | AAA | Submitted on the opposite strand | 495/495 (100 %) | 3 diff (99.4 %id) | |
CA775691 | Pancreas, Purified pancreatic islet | .g | 1150 to 1564 | 426 to 12 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 415/415 (100 %) | 5 diff (98.8 %id) | |
CA775976 | Pancreas, Purified pancreatic islet | .g | 623 to 1211 | 1 to 589 | fully sequenced, | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 589/589 (100 %) | 4 diff (99.4 %id) | |
BQ424677 | eye, retinoblastoma | .c | 15 to 907 | 1 to 901 | S202V I203Y S204F R205T P206T ... | 901/901 (100 %) | 16 diff (98.3 %id) | ||
BU161635 | melanotic melanoma, skin | .c | 20 to 817 | 1 to 803 | R224K M225N D226G | 803/835 (96 %) | 5 diff (99.5 %id) | ||
BU189028 | melanotic melanoma, skin | .b | 148 to 1001 | 1 to 866 | S211I S225I G226X S227K P228S ... | 866/895 (96 %) | 20 diff (97.8 %id) | ||
BU166783 | melanotic melanoma, skin | .b | 148 to 1018 | 1 to 879 | E235* | 879/898 (97 %) | 13 diff (98.6 %id) | ||
BU184097 | melanotic melanoma, skin | .b | 156 to 947 | 1 to 796 | 796/843 (94 %) | 8 diff (99.1 %id) | |||
BU179158 | eye, retinoblastoma | .b | 156 to 1015 | 1 to 873 | S225I G226R S227K P228V R229L ... | 873/908 (96 %) | 23 diff (97.5 %id) | ||
BU184592 | leiomyosarcoma, uterus | .b | 144 to 1036 | 1 to 903 | G186R S196A P218S G226R S227K ... | 903/905 (99 %) | 35 diff (96.2 %id) | ||
BQ889753 | dorsal root ganglia | .g | 76 to 860 | 1 to 793 | 793/864 (91 %) | 11 diff (98.8 %id) | |||
BQ720304 | sympathetic trunk | .m-u | 1 to 807 | 1 to 812 | tiling clone, | 812/906 (89 %) | 15 diff (98.4 %id) | ||
BQ890736 | sciatic nerve | .b | 148 to 1028 | 1 to 888 | G186R S196A S200F S208N S209H ... | 888/899 (98 %) | 29 diff (96.8 %id) | ||
BQ673856 | epidermoid carcinoma, cell line, salivary gland | .b | 228 to 1089 | 1 to 867 | G226X | 867/892 (97 %) | 8 diff (99.2 %id) | ||
CA774652 | Pancreas, Purified pancreatic islet | .b | 780 to 1195 | 417 to 2 | fully sequenced, | 416/417 (99 %) | 0 diff (100 %id) | ||
CA774887 | Pancreas, Purified pancreatic islet | .b | 150 to 841 | 7 to 697 | fully sequenced, | 691/697 (99 %) | 6 diff (99.2 %id) | ||
BU929323 | placenta | .c | 650 to 1023 | 1 to 374 | 374/412 (90 %) | 3 diff (99.3 %id) | |||
BU942928 | mixed (pool of 40 RNAs) | .c | 457 to 1205 | 1 to 751 | 751/751 (100 %) | 4 diff (99.5 %id) | |||
CX166267 | human embryonic stem cells differentiated toan early endodermal cell type | .i | 70 to 897 | 1 to 828 | exact | 828/828 (100 %) | 0 diff (100 %id) | ||
CX785290 | human embryonic stem cells | .b | 148 to 925 | 1 to 778 | 778/778 (100 %) | 0 diff (100 %id) | |||
CV804088 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 147 to 863 | 1 to 717 | 717/885 (81 %) | 2 diff (99.8 %id) | |||
CX751240 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 142 to 898 | 1 to 757 | Submitted on the opposite strand | 757/758 (99 %) | 2 diff (99.8 %id) | ||
CX753309 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 1294 to 1998 | 724 to 20 | 705/725 (97 %) | 0 diff (100 %id) | |||
DR763417 | embryonic stem | .b | 160 to 853 | 1 to 694 | 694/694 (100 %) | 0 diff (100 %id) | |||
CB963869 | Blood vessels - aorta, basilar and artery | .j | 1324 to 1746 | 1 to 423 | tiling clone, | 423/460 (91 %) | 4 diff (99.2 %id) | ||
CB956891 | Pooled-Glandular | .a | 1042 to 1718 | 1 to 680 | tiling clone, | 680/762 (89 %) | 9 diff (98.9 %id) | ||
CB956167 | Pooled-Glandular | .g | 56 to 639 | 1 to 589 | 589/620 (95 %) | 12 diff (98.1 %id) | |||
CD172235 | White Matter | .g | 54 to 867 | 13 to 829 | 817/911 (89 %) | 10 diff (99.0 %id) | |||
CD517543 | White Matter | .i | 769 to 1604 | 27 to 862 | 836/906 (92 %) | 22 diff (97.6 %id) | |||
CD522756 | pooled | .g | 54 to 684 | 1 to 641 | 641/897 (71 %) | 36 diff (96.0 %id) | |||
CF126066 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 24 to 775 | 1 to 752 | 752/755 (99 %) | 1 diff (99.9 %id) | |||
CF597200 | ovary | .i | 52 to 688 | 1 to 650 | R125P R126K R127K S128K R129Q ... | 650/798 (81 %) | 28 diff (96.5 %id) | ||
DA610616 | .i | 59 to 621 | 2 to 564 | G16D F51L | capped | 563/563 (100 %) | 2 diff (99.7 %id) | ||
DA612881 | .g | 56 to 650 | 2 to 594 | capped | 593/593 (100 %) | 1 diff (99.9 %id) | |||
DA615369 | .b | 134 to 710 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | |||
DA616313 | .b | 135 to 710 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | |||
DA616625 | .b | 135 to 697 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | |||
TI_43960434 | .i | 66 to 888 | 67 to 890 | exact | 824/890 (92 %) | 15 diff (98.4 %id) | |||
TI_45235555 | .i | 75 to 810 | 56 to 793 | exact | 738/793 (93 %) | 8 diff (99.0 %id) | |||
TI_45235556 | .i | 1265 to 1915 | 693 to 28 | 666/839 (79 %) | 25 diff (97.1 %id) | ||||
TI_45215403 | .g | 54 to 1018 | 121 to 1080 | 960/1117 (85 %) | 49 diff (95.7 %id) | ||||
TI_44351048 | .c | 3 to 745 | 116 to 864 | 749/864 (86 %) | 21 diff (97.6 %id) | ||||
TI_44345805 | .g | 55 to 782 | 87 to 813 | 727/814 (89 %) | 10 diff (98.8 %id) | ||||
TI_44346026 | .b | 133 to 1035 | 88 to 993 | E55* | 906/995 (91 %) | 22 diff (97.8 %id) | |||
TI_59391502 | .g | 75 to 721 | 126 to 811 | 683/1031 (66 %) | 35 diff (96.7 %id) | ||||
BP271045 | small intestine | .g | 55 to 635 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
BP275231 | Kidney | .b | 136 to 717 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP277353 | Kidney | .i | 52 to 593 | 1 to 542 | C106R Y122H R124P R126T Y130H ... | 542/563 (96 %) | 19 diff (96.7 %id) | ||
DA634592 | Kidney | .b | 134 to 700 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
CB135504 | Liver | .k | 639 to 1057 | 1 to 419 | 419/419 (100 %) | 1 diff (99.8 %id) | |||
L22253 | .b | 134 to 1103 | 1 to 970 | exact | 970/971 (99 %) | 1 diff (99.9 %id) | |||
DA639872 | Liver | .i | 56 to 640 | 2 to 586 | exact | capped | 585/585 (100 %) | 0 diff (100 %id) | |
BP291829 | lung | .i | 56 to 637 | 1 to 582 | K112N | 582/582 (100 %) | 1 diff (99.9 %id) | ||
BP293237 | lung | .i | 56 to 637 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | ||
BP293487 | lung | .i | 56 to 637 | 1 to 582 | exact | 582/582 (100 %) | 2 diff (99.7 %id) | ||
DA643997 | .b | 137 to 725 | 2 to 590 | capped | 589/589 (100 %) | 0 diff (100 %id) | |||
DA645380 | .i | 59 to 643 | 2 to 586 | G8R G9R E10R T11N K12Q ... | capped | 585/585 (100 %) | 4 diff (99.4 %id) | ||
AV761552 | bone marrow | .a | 976 to 1660 | 1 to 674 | tiling clone, | 674/675 (99 %) | 28 diff (95.9 %id) | ||
DA656985 | .b | 135 to 395 | 2 to 262 | capped | 261/261 (100 %) | 0 diff (100 %id) | |||
DA679076 | .b | 135 to 697 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | |||
NM_001031684.2 | .b | 1 to 2489 | 1 to 2489 | exact | RefSeq, | 2489/2489 (100 %) | 0 diff (100 %id) | ||
AV747744 | Pituitary | .a | 1602 to 1932 | 1 to 324 | 324/326 (99 %) | 4 diff (98.8 %id) | |||
AV746930 | Pituitary | .i | 145 to 630 | 1 to 481 | R65X R97X F100L D101I P102Q ... | 481/488 (98 %) | 13 diff (97.4 %id) | ||
DA687546 | .i | 59 to 592 | 2 to 536 | G21W A22R G23W K24Q G25R ... | capped | 535/535 (100 %) | 1 diff (99.9 %id) | ||
DA691061 | .b | 137 to 710 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | |||
DA692227 | .b | 135 to 705 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | |||
DA706870 | .b | 134 to 720 | 2 to 588 | capped | 587/587 (100 %) | 0 diff (100 %id) | |||
DA719617 | .b | 135 to 635 | 2 to 502 | capped | 501/501 (100 %) | 0 diff (100 %id) | |||
AU128135 | .i | 57 to 521 | 2 to 466 | capped | 465/465 (100 %) | 4 diff (99.2 %id) | |||
AU150447 | .i | 2435 to 2973 | 538 to 1 | tiling clone, | 538/541 (99 %) | 8 diff (98.6 %id) | |||
AU130595 | .c | 7 to 876 | 2 to 867 | exact | capped | 866/870 (99 %) | 8 diff (99.1 %id) | ||
AU152514 | .c | 1765 to 2317 | 552 to 1 | 552/554 (99 %) | 10 diff (98.2 %id) | ||||
DA736910 | .l | 2 to 704 | 2 to 704 | exact | capped | 703/703 (100 %) | 0 diff (100 %id) | ||
DB369482 | .l | 1439 to 1899 | 460 to 1 | 460/517 (88 %) | 5 diff (99.1 %id) | ||||
DA747034 | .b | 134 to 699 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
DA749315 | .e | 1 to 561 | 2 to 562 | tiling clone, capped | 561/561 (100 %) | 1 diff (99.9 %id) | |||
DA753034 | .i | 57 to 621 | 2 to 566 | exact | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
DA773505 | brain | .g | 56 to 614 | 2 to 561 | capped | 560/563 (99 %) | 2 diff (99.7 %id) | ||
DA807014 | brain | .i | 59 to 629 | 2 to 572 | exact | capped | 571/571 (100 %) | 0 diff (100 %id) | |
DA816359 | .b | 135 to 635 | 2 to 502 | capped | 501/501 (100 %) | 0 diff (100 %id) | |||
DA819622 | .b | 135 to 706 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | |||
DA822159 | pericardium | .g | 58 to 625 | 2 to 572 | capped | 571/571 (100 %) | 3 diff (99.5 %id) | ||
AU135625 | placenta | .i | 57 to 851 | 2 to 802 | exact | capped | 801/828 (96 %) | 19 diff (97.8 %id) | |
AU156184 | placenta | .i | 1517 to 1991 | 475 to 1 | 473/475 (99 %) | 7 diff (98.6 %id) | |||
AU135640 | placenta | .i | 59 to 774 | 2 to 720 | R129X | capped | 719/822 (87 %) | 9 diff (99.0 %id) | |
DB373921 | placenta | .i | 1659 to 1991 | 334 to 1 | 334/494 (67 %) | 2 diff (99.6 %id) | |||
AU136151 | placenta | .b | 135 to 810 | 2 to 679 | capped | 678/713 (95 %) | 6 diff (99.2 %id) | ||
AU156525 | placenta | .b | 1819 to 2176 | 358 to 1 | 358/358 (100 %) | 3 diff (99.2 %id) | |||
AU136198 | placenta | .b | 137 to 878 | 2 to 744 | capped | 743/743 (100 %) | 7 diff (99.1 %id) | ||
AU156559 | placenta | .b | 2017 to 2487 | 474 to 1 | tiling clone, | 474/474 (100 %) | 9 diff (98.2 %id) | ||
AU137154 | placenta | .i | 57 to 781 | 2 to 732 | exact | capped | 731/843 (86 %) | 13 diff (98.5 %id) | |
AU157048 | placenta | .i | 1603 to 1991 | 389 to 1 | 389/418 (93 %) | 3 diff (99.3 %id) | |||
AU137271 | placenta | .i | 332 to 1118 | 2 to 795 | capped | 794/801 (99 %) | 15 diff (98.2 %id) | ||
AU157104 | placenta | .i | 2768 to 3284 | 513 to 1 | tiling clone, | 513/583 (87 %) | 11 diff (98.2 %id) | ||
AU138730 | placenta | .l | 1 to 760 | 2 to 763 | exact | tiling clone, capped | 762/768 (99 %) | 8 diff (99.0 %id) | |
DB378684 | placenta | .l | 1412 to 1899 | 487 to 1 | 487/502 (97 %) | 2 diff (99.7 %id) | |||
DA842220 | placenta | .i | 57 to 624 | 2 to 569 | exact | capped | 568/568 (100 %) | 1 diff (99.9 %id) | |
DA846814 | placenta | .b | 409 to 990 | 2 to 583 | capped | 582/582 (100 %) | 0 diff (100 %id) | ||
DA865398 | Prostate | .j | 2 to 532 | 2 to 533 | N17* | capped | 532/532 (100 %) | 1 diff (99.9 %id) | |
DB329371 | Prostate | .j | 2222 to 2727 | 506 to 1 | tiling clone, | 506/506 (100 %) | 0 diff (100 %id) | ||
DA869741 | Prostate | .b | 137 to 685 | 2 to 550 | capped | 549/549 (100 %) | 0 diff (100 %id) | ||
BP331382 | rectum | .i | 461 to 1042 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
CR989448 | T-Lymphocytes | .i | 68 to 726 | 1 to 659 | exact | 659/664 (99 %) | 1 diff (99.9 %id) | ||
CR981519 | T-Lymphocytes | .b | 146 to 855 | 1 to 715 | 713/782 (91 %) | 6 diff (99.3 %id) | |||
CR985928 | T-Lymphocytes | .b | 146 to 863 | 1 to 720 | 720/766 (93 %) | 3 diff (99.7 %id) | |||
CR986453 | T-Lymphocytes | .b | 146 to 900 | 1 to 755 | 755/762 (99 %) | 2 diff (99.8 %id) | |||
CR976702 | T-Lymphocytes | .b | 149 to 896 | 1 to 749 | 749/802 (93 %) | 2 diff (99.8 %id) | |||
CR993168 | T-Lymphocytes | .b | 146 to 899 | 1 to 754 | 754/780 (96 %) | 3 diff (99.7 %id) | |||
CT005059 | T-Lymphocytes | .i | 71 to 828 | 32 to 789 | exact | 758/789 (96 %) | 6 diff (99.3 %id) | ||
CR975299 | T-Lymphocytes | .b | 146 to 971 | 1 to 832 | G186X S187I R188E Y189V Q191P ... | 832/832 (100 %) | 8 diff (99.1 %id) | ||
CR979262 | T-Lymphocytes | .b | 149 to 969 | 1 to 827 | S187I R188E Y189V Q191P S192I ... | 827/827 (100 %) | 10 diff (98.8 %id) | ||
CR985880 | T-Lymphocytes | .b | 155 to 1009 | 1 to 858 | R229S R230Q S231K A232C S233K ... | 858/860 (99 %) | 4 diff (99.6 %id) | ||
CR996455 | T-Lymphocytes | .o-u | 1 to 544 | 1 to 544 | 544/546 (99 %) | 1 diff (99.9 %id) | |||
CR999853 | T-Lymphocytes | .g | 67 to 920 | 1 to 857 | 857/857 (100 %) | 3 diff (99.7 %id) | |||
CR975553 | T-Lymphocytes | .o-u | 4 to 530 | 1 to 527 | 527/528 (99 %) | 1 diff (99.9 %id) | |||
CR988538 | T-Lymphocytes | .o-u | 1 to 600 | 1 to 600 | tiling clone, | 600/607 (98 %) | 1 diff (99.9 %id) | ||
CR999658 | T-Lymphocytes | .o-u | 388 to 866 | 1 to 479 | exact | tiling clone, | 479/479 (100 %) | 0 diff (100 %id) | |
BM785067 | Ascites, stomach | .b | 136 to 514 | 1 to 379 | 379/379 (100 %) | 0 diff (100 %id) | |||
BM788206 | Ascites, stomach | .b | 136 to 766 | 1 to 631 | 631/631 (100 %) | 0 diff (100 %id) | |||
BM829487 | Ascites, stomach | .g | 55 to 632 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
BM827691 | stomach | .b | 134 to 652 | 1 to 519 | 519/519 (100 %) | 0 diff (100 %id) | |||
BM834524 | stomach | .b | 136 to 651 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM841268 | lymph node, stomach | .i | 1210 to 1619 | 1 to 409 | 409/409 (100 %) | 5 diff (98.8 %id) | |||
BQ084417 | stomach | .b | 136 to 417 | 1 to 282 | 282/282 (100 %) | 0 diff (100 %id) | |||
BM795834 | stomach | .c | 2124 to 2314 | 1 to 191 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 191/191 (100 %) | 0 diff (100 %id) | |
BM817651 | stomach | .c | 824 to 1028 | 1 to 205 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 205/205 (100 %) | 0 diff (100 %id) | |
BM797375 | Ascites, stomach | .b | 299 to 654 | 1 to 356 | 356/356 (100 %) | 0 diff (100 %id) | |||
DA894785 | skeletal muscle | .g | 56 to 622 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
BP333081 | salivary gland | .i | 55 to 635 | 1 to 581 | G110R E111X R121X S123T R124P ... | 581/581 (100 %) | 25 diff (95.7 %id) | ||
DA933609 | Spleen | .i | 56 to 591 | 2 to 538 | R3L Y4L G5R R6A Y7V ... | capped | 537/537 (100 %) | 2 diff (99.7 %id) | |
DA934612 | Spleen | .g | 56 to 627 | 2 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | ||
DA936900 | Spleen | .i | 57 to 626 | 2 to 573 | R6L Y7V G8R G9R E10R ... | capped | 572/572 (100 %) | 3 diff (99.5 %id) | |
DA937160 | Spleen | .i | 449 to 1031 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | ||
DA945617 | Spleen | .q | 1 to 541 | 2 to 545 | G17W L18S D19R H20S I21H ... | tiling clone, capped | 542/544 (99 %) | 5 diff (99.1 %id) | |
DA956109 | Spleen | .b | 135 to 693 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA956195 | Spleen | .o-u | 45 to 595 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | ||
DA956549 | Spleen | .g | 56 to 594 | 2 to 545 | capped | 544/544 (100 %) | 5 diff (99.1 %id) | ||
BP342651 | stomach mucosa | .i | 58 to 641 | 1 to 584 | exact | 584/584 (100 %) | 0 diff (100 %id) | ||
BP347674 | brain | .b | 136 to 719 | 1 to 584 | 584/584 (100 %) | 0 diff (100 %id) | |||
DN993725 | brain, whole brain | .i | 88 to 707 | 1 to 620 | exact | 620/620 (100 %) | 5 diff (99.2 %id) | ||
BM149665 | leukopheresis | .i | 868 to 1386 | 1 to 518 | 518/518 (100 %) | 3 diff (99.5 %id) | |||
DB013909 | esophageal, tumor tissue | .i | 59 to 605 | 2 to 548 | exact | capped | 547/547 (100 %) | 0 diff (100 %id) | |
DB018317 | esophageal, tumor tissue | .i | 56 to 622 | 2 to 569 | G21W A22R G23X K24A G25K ... | capped | 568/568 (100 %) | 3 diff (99.5 %id) | |
DB019173 | esophageal, tumor tissue | .i | 60 to 639 | 2 to 583 | T20N G21L G23L K24A G25K ... | capped | 582/582 (100 %) | 2 diff (99.7 %id) | |
DB026789 | testis | .b | 137 to 699 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB036304 | testis | .b | 137 to 713 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DB068515 | testis | .i | 608 to 1141 | 2 to 535 | capped | 534/534 (100 %) | 0 diff (100 %id) | ||
DB102044 | thymus | .i | 56 to 600 | 2 to 546 | C73R | capped | 545/545 (100 %) | 1 diff (99.9 %id) | |
DB109503 | thymus | .i | 55 to 611 | 2 to 559 | G5R R6A Y7V G8R G9R ... | capped | 558/561 (99 %) | 4 diff (99.3 %id) | |
DB110025 | thymus | .g | 56 to 639 | 2 to 586 | capped | 585/585 (100 %) | 1 diff (99.9 %id) | ||
DB112018 | thymus | .i | 57 to 674 | 2 to 619 | exact | capped | 618/618 (100 %) | 0 diff (100 %id) | |
DB343478. matches multiple genes | thymus | .c | 1773 to 2317 | 545 to 1 | also hits gene rira | 545/545 (100 %) | 0 diff (100 %id) | ||
DB116958 | thymus | .b | 135 to 626 | 2 to 493 | capped | 492/492 (100 %) | 0 diff (100 %id) | ||
DB119897 | thymus | .i | 57 to 592 | 2 to 537 | exact | capped | 536/536 (100 %) | 0 diff (100 %id) | |
DB139108 | thymus | .i | 57 to 601 | 2 to 548 | R3Q Y4L G5R R6A Y7V ... | capped | 547/547 (100 %) | 4 diff (99.3 %id) | |
DB144743 | thymus | .i | 56 to 600 | 2 to 547 | R3Q Y4L G5R R6A Y7V ... | capped | 546/546 (100 %) | 1 diff (99.9 %id) | |
DB152825 | thymus | .i | 57 to 616 | 2 to 562 | G8R G9R E10R T11N K12Q ... | capped | 561/561 (100 %) | 2 diff (99.7 %id) | |
DB158904 | thymus | .i | 57 to 648 | 2 to 593 | exact | capped | 592/592 (100 %) | 3 diff (99.5 %id) | |
TI_149271059 | .l | 1146 to 1899 | 827 to 84 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 744/933 (79 %) | 11 diff (98.9 %id) | ||
TI_149275154 | .c | 1511 to 1882 | 284 to 655 | AAA | Submitted on the opposite strand | 372/811 (45 %) | 19 diff (97.7 %id) | ||
TI_149277873 | .c | 1455 to 2317 | 947 to 94 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 854/1068 (79 %) | 19 diff (98.3 %id) | ||
TI_149289669 | .b | 457 to 1194 | 828 to 90 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 739/937 (78 %) | 7 diff (99.3 %id) | ||
TI_149290445 | .g | 874 to 1564 | 777 to 88 | S6R T7P C8A K9N A11Q ... | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 690/803 (85 %) | 9 diff (98.9 %id) | |
TI_149313724 | .b | 329 to 1194 | 948 to 90 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 859/983 (87 %) | 12 diff (98.8 %id) | ||
TI_154094957 | .i | 624 to 1263 | 765 to 118 | AAA | 648/895 (72 %) | 13 diff (98.6 %id) | |||
TI_154095154 | .i | 775 to 1263 | 589 to 101 | AAA | 489/1184 (41 %) | 23 diff (98.1 %id) | |||
TI_154109411 | .k | 430 to 1213 | 840 to 67 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 774/963 (80 %) | 13 diff (98.7 %id) | ||
TI_154112261 | .a | 1139 to 1997 | 927 to 82 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 846/950 (89 %) | 10 diff (99.0 %id) | ||
TI_154117555 | .j | 1185 to 1746 | 696 to 140 | tiling clone, | 557/999 (55 %) | 9 diff (99.1 %id) | |||
TI_154188898 | .c | 24 to 879 | 49 to 901 | R170X R180X E223G R224E | 853/1025 (83 %) | 13 diff (98.8 %id) | |||
TI_159722309 | .c | 1412 to 2321 | 967 to 78 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 890/964 (92 %) | 28 diff (97.1 %id) | ||
DB178582 | kidney, tumor tissue | .k | 116 to 671 | 2 to 557 | tiling clone, capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
DB185741 | liver, tumor tissue | .i | 57 to 630 | 2 to 577 | G21W A22R G23X K24A G25K ... | capped | 576/576 (100 %) | 4 diff (99.4 %id) | |
BP366589 | thymus | .i | 55 to 635 | 1 to 581 | S123R | 581/581 (100 %) | 4 diff (99.4 %id) | ||
DB197716 | trachea | .b | 135 to 723 | 2 to 590 | capped | 589/589 (100 %) | 0 diff (100 %id) | ||
DB213462 | trachea | .i | 55 to 629 | 2 to 576 | exact | capped | 575/575 (100 %) | 2 diff (99.7 %id) | |
DB225737 | trachea | .g | 56 to 624 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | ||
BP369356 | testis | .b | 134 to 713 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DB245635 | uterus, tumor tissue | .b | 811 to 1367 | 3 to 559 | capped | 557/558 (99 %) | 0 diff (100 %id) | ||
BP374996 | umbilical cord | .b | 134 to 715 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BU674172 | lung, Primary Lung Epithelial Cells | .l | 1288 to 1899 | 628 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 612/612 (100 %) | 0 diff (100 %id) | |
BU678024 | lung | .c | 1685 to 2317 | 648 to 16 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 633/633 (100 %) | 0 diff (100 %id) | |
BM971029 | lung | .b | 538 to 1194 | 673 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 657/657 (100 %) | 3 diff (99.6 %id) | |
BM973439 | lung | .g | 952 to 1564 | 628 to 17 | S6R T7P C8A K9N A11Q ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 612/612 (100 %) | 1 diff (99.9 %id) |
CB305576 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .b | 478 to 1194 | 733 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 717/717 (100 %) | 0 diff (100 %id) | |
CB853076 | Human Lung Epithelial cells, lung | .c | 1633 to 2321 | 702 to 15 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 688/690 (99 %) | 2 diff (99.8 %id) | |
CB241049 | Human Lung Epithelial cells, lung | .i | 1250 to 1493 | 12 to 255 | Submitted on the opposite strand | 244/259 (94 %) | 4 diff (98.5 %id) | ||
BM662236 | eye, RPE and Choroid | .i | 1584 to 1992 | 424 to 17 | 408/424 (96 %) | 0 diff (100 %id) | |||
BM691594 | eye, RPE and Choroid | .i | 870 to 1402 | 1 to 533 | 533/533 (100 %) | 5 diff (99.1 %id) | |||
BM665923 | eye, fetal eyes | .c | 1369 to 2010 | 660 to 17 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 644/644 (100 %) | 1 diff (99.9 %id) | |
BM711343 | eye, fetal eyes | .c | 878 to 1178 | 1 to 301 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 301/301 (100 %) | 0 diff (100 %id) | ||
BM699539 | eye, fetal eyes | .c | 1461 to 1847 | 1 to 387 | fully sequenced, | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 387/387 (100 %) | 0 diff (100 %id) | |
BU737276 | eye, fetal eyes | .c | 1817 to 2321 | 519 to 15 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 505/505 (100 %) | 0 diff (100 %id) | |
BM678631 | eye, fetal eye | .i | 571 to 1308 | 9 to 745 | Submitted on the opposite strand | 737/745 (98 %) | 6 diff (99.2 %id) | ||
CA436650 | Bone, Subchondral Bone | .i | 837 to 1263 | 445 to 19 | AAA | 427/427 (100 %) | 0 diff (100 %id) | ||
CA444864 | lung, Metastatic Chondrosarcoma | .k | 663 to 1215 | 569 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 553/553 (100 %) | 1 diff (99.9 %id) | |
CA447876 | Chondrosarcoma, Left Pelvis | .k | 535 to 1213 | 697 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 679/679 (100 %) | 1 diff (99.9 %id) | |
CA448568 | Chondrosarcoma, Left Pelvis | .a | 1280 to 1997 | 734 to 17 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 718/718 (100 %) | 2 diff (99.8 %id) | |
CA413115 | Chondrosarcoma Grade II, Left Pelvis | .k | 535 to 1215 | 699 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 681/681 (100 %) | 3 diff (99.6 %id) | |
CA430673 | cell lines, Chondrosarcoma | .i | 1303 to 1991 | 707 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 689/691 (99 %) | 0 diff (100 %id) | |
CB529379 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529530 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529764 | Aveolar Macrophage, lung | .b | 539 to 1194 | 672 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 656/656 (100 %) | 0 diff (100 %id) | |
DB262482 | uterus | .h | 3 to 566 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
DB267327 | uterus | .g | 52 to 640 | 2 to 590 | capped | 589/589 (100 %) | 4 diff (99.4 %id) | ||
DB271149 | uterus | .g | 56 to 608 | 2 to 557 | capped | 556/556 (100 %) | 3 diff (99.5 %id) | ||
DB273872 | uterus | .i | 57 to 630 | 2 to 575 | R105S | capped | 574/574 (100 %) | 2 diff (99.7 %id) | |
W22212 | eye, retina | .g | 773 to 1235 | 1 to 465 | 465/700 (66 %) | 12 diff (98.3 %id) | |||
BP376203 | uterus | .g | 55 to 635 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | |||
BP376353 | uterus | .g | 237 to 806 | 1 to 570 | 570/570 (100 %) | 0 diff (100 %id) | |||
BP378046 | uterus | .i | 332 to 903 | 1 to 572 | 572/572 (100 %) | 0 diff (100 %id) | |||
BP378302 | uterus | .i | 618 to 1197 | 1 to 580 | 580/580 (100 %) | 1 diff (99.9 %id) | |||
AK225141 | cerebellum | .i | 68 to 726 | 1 to 659 | AAA | Suspected internal deletion, this clone was ignored | 659/664 (99 %) | 1 diff (99.9 %id) | |
AK293667 | cerebellum | .b | 146 to 855 | 1 to 715 | Suspected internal deletion, this clone was ignored | 713/782 (91 %) | 6 diff (99.3 %id) | ||
CR985928 | T-Lymphocytes | .b | 146 to 863 | 1 to 720 | 720/766 (93 %) | 3 diff (99.7 %id) | |||
CR986453 | T-Lymphocytes | .b | 146 to 900 | 1 to 755 | 755/762 (99 %) | 2 diff (99.8 %id) | |||
CR976702 | T-Lymphocytes | .b | 149 to 896 | 1 to 749 | 749/802 (93 %) | 2 diff (99.8 %id) | |||
CR993168 | T-Lymphocytes | .b | 146 to 899 | 1 to 754 | 754/780 (96 %) | 3 diff (99.7 %id) | |||
CT005059 | T-Lymphocytes | .i | 71 to 828 | 32 to 789 | exact | 758/789 (96 %) | 6 diff (99.3 %id) | ||
CR975299 | T-Lymphocytes | .b | 146 to 971 | 1 to 832 | G186X S187I R188E Y189V Q191P ... | 832/832 (100 %) | 8 diff (99.1 %id) | ||
CR979262 | T-Lymphocytes | .b | 149 to 969 | 1 to 827 | S187I R188E Y189V Q191P S192I ... | 827/827 (100 %) | 10 diff (98.8 %id) | ||
CR985880 | T-Lymphocytes | .b | 155 to 1009 | 1 to 858 | R229S R230Q S231K A232C S233K ... | 858/860 (99 %) | 4 diff (99.6 %id) | ||
CR996455 | T-Lymphocytes | .o-u | 1 to 544 | 1 to 544 | 544/546 (99 %) | 1 diff (99.9 %id) | |||
CR999853 | T-Lymphocytes | .g | 67 to 920 | 1 to 857 | 857/857 (100 %) | 3 diff (99.7 %id) | |||
CR975553 | T-Lymphocytes | .o-u | 4 to 530 | 1 to 527 | 527/528 (99 %) | 1 diff (99.9 %id) | |||
CR988538 | T-Lymphocytes | .o-u | 1 to 600 | 1 to 600 | tiling clone, | 600/607 (98 %) | 1 diff (99.9 %id) | ||
CR999658 | T-Lymphocytes | .o-u | 388 to 866 | 1 to 479 | exact | tiling clone, | 479/479 (100 %) | 0 diff (100 %id) | |
BM785067 | Ascites, stomach | .b | 136 to 514 | 1 to 379 | 379/379 (100 %) | 0 diff (100 %id) | |||
BM785067 | Ascites, stomach | .b | 136 to 514 | 1 to 379 | 379/379 (100 %) | 0 diff (100 %id) | |||
BM788206 | Ascites, stomach | .b | 136 to 766 | 1 to 631 | 631/631 (100 %) | 0 diff (100 %id) | |||
BM788206 | Ascites, stomach | .b | 136 to 766 | 1 to 631 | 631/631 (100 %) | 0 diff (100 %id) | |||
BM829487 | Ascites, stomach | .g | 55 to 632 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
BM829487 | Ascites, stomach | .g | 55 to 632 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
BM827691 | stomach | .b | 134 to 652 | 1 to 519 | 519/519 (100 %) | 0 diff (100 %id) | |||
BM834524 | stomach | .b | 136 to 651 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM841268 | lymph node, stomach | .i | 1210 to 1619 | 1 to 409 | 409/409 (100 %) | 5 diff (98.8 %id) | |||
BM841268 | lymph node, stomach | .i | 1210 to 1619 | 1 to 409 | 409/409 (100 %) | 5 diff (98.8 %id) | |||
BQ084417 | stomach | .b | 136 to 417 | 1 to 282 | 282/282 (100 %) | 0 diff (100 %id) | |||
BM795834 | stomach | .c | 2124 to 2314 | 1 to 191 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 191/191 (100 %) | 0 diff (100 %id) | |
BM817651 | stomach | .c | 824 to 1028 | 1 to 205 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 205/205 (100 %) | 0 diff (100 %id) | |
BM797375 | Ascites, stomach | .b | 299 to 654 | 1 to 356 | 356/356 (100 %) | 0 diff (100 %id) | |||
BM797375 | Ascites, stomach | .b | 299 to 654 | 1 to 356 | 356/356 (100 %) | 0 diff (100 %id) | |||
DA894785 | skeletal muscle | .g | 56 to 622 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
BP333081 | salivary gland | .i | 55 to 635 | 1 to 581 | G110R E111X R121X S123T R124P ... | 581/581 (100 %) | 25 diff (95.7 %id) | ||
DA933609 | Spleen | .i | 56 to 591 | 2 to 538 | R3L Y4L G5R R6A Y7V ... | capped | 537/537 (100 %) | 2 diff (99.7 %id) | |
DA934612 | Spleen | .g | 56 to 627 | 2 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | ||
DA936900 | Spleen | .i | 57 to 626 | 2 to 573 | R6L Y7V G8R G9R E10R ... | capped | 572/572 (100 %) | 3 diff (99.5 %id) | |
DA937160 | Spleen | .i | 449 to 1031 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | ||
DA945617 | Spleen | .q | 1 to 541 | 2 to 545 | G17W L18S D19R H20S I21H ... | tiling clone, capped | 542/544 (99 %) | 5 diff (99.1 %id) | |
DA956109 | Spleen | .b | 135 to 693 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA956195 | Spleen | .o-u | 45 to 595 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | ||
DA956549 | Spleen | .g | 56 to 594 | 2 to 545 | capped | 544/544 (100 %) | 5 diff (99.1 %id) | ||
BP342651 | stomach mucosa | .i | 58 to 641 | 1 to 584 | exact | 584/584 (100 %) | 0 diff (100 %id) | ||
BP347674 | brain | .b | 136 to 719 | 1 to 584 | 584/584 (100 %) | 0 diff (100 %id) | |||
DN993725 | brain, whole brain | .i | 88 to 707 | 1 to 620 | exact | 620/620 (100 %) | 5 diff (99.2 %id) | ||
DN993725 | brain, whole brain | .i | 88 to 707 | 1 to 620 | exact | 620/620 (100 %) | 5 diff (99.2 %id) | ||
BM149665 | leukopheresis | .i | 868 to 1386 | 1 to 518 | 518/518 (100 %) | 3 diff (99.5 %id) | |||
DB013909 | esophageal, tumor tissue | .i | 59 to 605 | 2 to 548 | exact | capped | 547/547 (100 %) | 0 diff (100 %id) | |
DB018317 | esophageal, tumor tissue | .i | 56 to 622 | 2 to 569 | G21W A22R G23X K24A G25K ... | capped | 568/568 (100 %) | 3 diff (99.5 %id) | |
DB019173 | esophageal, tumor tissue | .i | 60 to 639 | 2 to 583 | T20N G21L G23L K24A G25K ... | capped | 582/582 (100 %) | 2 diff (99.7 %id) | |
DB026789 | testis | .b | 137 to 699 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB036304 | testis | .b | 137 to 713 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DB068515 | testis | .i | 608 to 1141 | 2 to 535 | capped | 534/534 (100 %) | 0 diff (100 %id) | ||
DB102044 | thymus | .i | 56 to 600 | 2 to 546 | C73R | capped | 545/545 (100 %) | 1 diff (99.9 %id) | |
DB109503 | thymus | .i | 55 to 611 | 2 to 559 | G5R R6A Y7V G8R G9R ... | capped | 558/561 (99 %) | 4 diff (99.3 %id) | |
DB110025 | thymus | .g | 56 to 639 | 2 to 586 | capped | 585/585 (100 %) | 1 diff (99.9 %id) | ||
DB112018 | thymus | .i | 57 to 674 | 2 to 619 | exact | capped | 618/618 (100 %) | 0 diff (100 %id) | |
DB343478. matches multiple genes | thymus | .c | 1773 to 2317 | 545 to 1 | also hits gene rira | 545/545 (100 %) | 0 diff (100 %id) | ||
DB116958 | thymus | .b | 135 to 626 | 2 to 493 | capped | 492/492 (100 %) | 0 diff (100 %id) | ||
DB119897 | thymus | .i | 57 to 592 | 2 to 537 | exact | capped | 536/536 (100 %) | 0 diff (100 %id) | |
DB139108 | thymus | .i | 57 to 601 | 2 to 548 | R3Q Y4L G5R R6A Y7V ... | capped | 547/547 (100 %) | 4 diff (99.3 %id) | |
DB144743 | thymus | .i | 56 to 600 | 2 to 547 | R3Q Y4L G5R R6A Y7V ... | capped | 546/546 (100 %) | 1 diff (99.9 %id) | |
DB152825 | thymus | .i | 57 to 616 | 2 to 562 | G8R G9R E10R T11N K12Q ... | capped | 561/561 (100 %) | 2 diff (99.7 %id) | |
DB158904 | thymus | .i | 57 to 648 | 2 to 593 | exact | capped | 592/592 (100 %) | 3 diff (99.5 %id) | |
TI_149271059 | .l | 1146 to 1899 | 827 to 84 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 744/933 (79 %) | 11 diff (98.9 %id) | ||
TI_149275154 | .c | 1511 to 1882 | 284 to 655 | AAA | Submitted on the opposite strand | 372/811 (45 %) | 19 diff (97.7 %id) | ||
TI_149277873 | .c | 1455 to 2317 | 947 to 94 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 854/1068 (79 %) | 19 diff (98.3 %id) | ||
TI_149289669 | .b | 457 to 1194 | 828 to 90 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 739/937 (78 %) | 7 diff (99.3 %id) | ||
TI_149290445 | .g | 874 to 1564 | 777 to 88 | S6R T7P C8A K9N A11Q ... | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 690/803 (85 %) | 9 diff (98.9 %id) | |
TI_149313724 | .b | 329 to 1194 | 948 to 90 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 859/983 (87 %) | 12 diff (98.8 %id) | ||
TI_154094957 | .i | 624 to 1263 | 765 to 118 | AAA | 648/895 (72 %) | 13 diff (98.6 %id) | |||
TI_154095154 | .i | 775 to 1263 | 589 to 101 | AAA | 489/1184 (41 %) | 23 diff (98.1 %id) | |||
TI_154109411 | .k | 430 to 1213 | 840 to 67 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 774/963 (80 %) | 13 diff (98.7 %id) | ||
TI_154112261 | .a | 1139 to 1997 | 927 to 82 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 846/950 (89 %) | 10 diff (99.0 %id) | ||
TI_154117555 | .j | 1185 to 1746 | 696 to 140 | tiling clone, | 557/999 (55 %) | 9 diff (99.1 %id) | |||
TI_154188898 | .c | 24 to 879 | 49 to 901 | R170X R180X E223G R224E | 853/1025 (83 %) | 13 diff (98.8 %id) | |||
TI_159722309 | .c | 1412 to 2321 | 967 to 78 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 890/964 (92 %) | 28 diff (97.1 %id) | ||
DB178582 | kidney, tumor tissue | .k | 116 to 671 | 2 to 557 | tiling clone, capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
DB185741 | liver, tumor tissue | .i | 57 to 630 | 2 to 577 | G21W A22R G23X K24A G25K ... | capped | 576/576 (100 %) | 4 diff (99.4 %id) | |
BP366589 | thymus | .i | 55 to 635 | 1 to 581 | S123R | 581/581 (100 %) | 4 diff (99.4 %id) | ||
DB197716 | trachea | .b | 135 to 723 | 2 to 590 | capped | 589/589 (100 %) | 0 diff (100 %id) | ||
DB213462 | trachea | .i | 55 to 629 | 2 to 576 | exact | capped | 575/575 (100 %) | 2 diff (99.7 %id) | |
DB225737 | trachea | .g | 56 to 624 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | ||
BP369356 | testis | .b | 134 to 713 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DB245635 | uterus, tumor tissue | .b | 811 to 1367 | 3 to 559 | capped | 557/558 (99 %) | 0 diff (100 %id) | ||
BP374996 | umbilical cord | .b | 134 to 715 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BU674172 | lung, Primary Lung Epithelial Cells | .l | 1288 to 1899 | 628 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 612/612 (100 %) | 0 diff (100 %id) | |
BU674172 | lung, Primary Lung Epithelial Cells | .l | 1288 to 1899 | 628 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 612/612 (100 %) | 0 diff (100 %id) | |
BU678024 | lung | .c | 1685 to 2317 | 648 to 16 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 633/633 (100 %) | 0 diff (100 %id) | |
BM971029 | lung | .b | 538 to 1194 | 673 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 657/657 (100 %) | 3 diff (99.6 %id) | |
BM973439 | lung | .g | 952 to 1564 | 628 to 17 | S6R T7P C8A K9N A11Q ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 612/612 (100 %) | 1 diff (99.9 %id) |
CB305576 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .b | 478 to 1194 | 733 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 717/717 (100 %) | 0 diff (100 %id) | |
CB305576 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .b | 478 to 1194 | 733 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 717/717 (100 %) | 0 diff (100 %id) | |
CB853076 | Human Lung Epithelial cells, lung | .c | 1633 to 2321 | 702 to 15 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 688/690 (99 %) | 2 diff (99.8 %id) | |
CB853076 | Human Lung Epithelial cells, lung | .c | 1633 to 2321 | 702 to 15 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 688/690 (99 %) | 2 diff (99.8 %id) | |
CB241049 | Human Lung Epithelial cells, lung | .i | 1250 to 1493 | 12 to 255 | Submitted on the opposite strand | 244/259 (94 %) | 4 diff (98.5 %id) | ||
CB241049 | Human Lung Epithelial cells, lung | .i | 1250 to 1493 | 12 to 255 | Submitted on the opposite strand | 244/259 (94 %) | 4 diff (98.5 %id) | ||
BM662236 | eye, RPE and Choroid | .i | 1584 to 1992 | 424 to 17 | 408/424 (96 %) | 0 diff (100 %id) | |||
BM662236 | eye, RPE and Choroid | .i | 1584 to 1992 | 424 to 17 | 408/424 (96 %) | 0 diff (100 %id) | |||
BM691594 | eye, RPE and Choroid | .i | 870 to 1402 | 1 to 533 | 533/533 (100 %) | 5 diff (99.1 %id) | |||
BM691594 | eye, RPE and Choroid | .i | 870 to 1402 | 1 to 533 | 533/533 (100 %) | 5 diff (99.1 %id) | |||
BM665923 | eye, fetal eyes | .c | 1369 to 2010 | 660 to 17 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 644/644 (100 %) | 1 diff (99.9 %id) | |
BM665923 | eye, fetal eyes | .c | 1369 to 2010 | 660 to 17 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 644/644 (100 %) | 1 diff (99.9 %id) | |
BM711343 | eye, fetal eyes | .c | 878 to 1178 | 1 to 301 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 301/301 (100 %) | 0 diff (100 %id) | ||
BM711343 | eye, fetal eyes | .c | 878 to 1178 | 1 to 301 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 301/301 (100 %) | 0 diff (100 %id) | ||
BM699539 | eye, fetal eyes | .c | 1461 to 1847 | 1 to 387 | fully sequenced, | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 387/387 (100 %) | 0 diff (100 %id) | |
BM699539 | eye, fetal eyes | .c | 1461 to 1847 | 1 to 387 | fully sequenced, | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 387/387 (100 %) | 0 diff (100 %id) | |
BU737276 | eye, fetal eyes | .c | 1817 to 2321 | 519 to 15 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 505/505 (100 %) | 0 diff (100 %id) | |
BU737276 | eye, fetal eyes | .c | 1817 to 2321 | 519 to 15 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 505/505 (100 %) | 0 diff (100 %id) | |
BM678631 | eye, fetal eye | .i | 571 to 1308 | 9 to 745 | Submitted on the opposite strand | 737/745 (98 %) | 6 diff (99.2 %id) | ||
BM678631 | eye, fetal eye | .i | 571 to 1308 | 9 to 745 | Submitted on the opposite strand | 737/745 (98 %) | 6 diff (99.2 %id) | ||
CA436650 | Bone, Subchondral Bone | .i | 837 to 1263 | 445 to 19 | AAA | 427/427 (100 %) | 0 diff (100 %id) | ||
CA436650 | Bone, Subchondral Bone | .i | 837 to 1263 | 445 to 19 | AAA | 427/427 (100 %) | 0 diff (100 %id) | ||
CA444864 | lung, Metastatic Chondrosarcoma | .k | 663 to 1215 | 569 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 553/553 (100 %) | 1 diff (99.9 %id) | |
CA444864 | lung, Metastatic Chondrosarcoma | .k | 663 to 1215 | 569 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 553/553 (100 %) | 1 diff (99.9 %id) | |
CA447876 | Chondrosarcoma, Left Pelvis | .k | 535 to 1213 | 697 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 679/679 (100 %) | 1 diff (99.9 %id) | |
CA447876 | Chondrosarcoma, Left Pelvis | .k | 535 to 1213 | 697 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 679/679 (100 %) | 1 diff (99.9 %id) | |
CA448568 | Chondrosarcoma, Left Pelvis | .a | 1280 to 1997 | 734 to 17 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 718/718 (100 %) | 2 diff (99.8 %id) | |
CA448568 | Chondrosarcoma, Left Pelvis | .a | 1280 to 1997 | 734 to 17 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 718/718 (100 %) | 2 diff (99.8 %id) | |
CA413115 | Chondrosarcoma Grade II, Left Pelvis | .k | 535 to 1215 | 699 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 681/681 (100 %) | 3 diff (99.6 %id) | |
CA413115 | Chondrosarcoma Grade II, Left Pelvis | .k | 535 to 1215 | 699 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 681/681 (100 %) | 3 diff (99.6 %id) | |
CA430673 | cell lines, Chondrosarcoma | .i | 1303 to 1991 | 707 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 689/691 (99 %) | 0 diff (100 %id) | |
CA430673 | cell lines, Chondrosarcoma | .i | 1303 to 1991 | 707 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 689/691 (99 %) | 0 diff (100 %id) | |
CB529379 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529379 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529530 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529530 | Aveolar Macrophage, lung | .b | 512 to 1194 | 699 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 683/683 (100 %) | 0 diff (100 %id) | |
CB529764 | Aveolar Macrophage, lung | .b | 539 to 1194 | 672 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 656/656 (100 %) | 0 diff (100 %id) | |
CB529764 | Aveolar Macrophage, lung | .b | 539 to 1194 | 672 to 17 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 656/656 (100 %) | 0 diff (100 %id) | |
DB262482 | uterus | .h | 3 to 566 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
DB267327 | uterus | .g | 52 to 640 | 2 to 590 | capped | 589/589 (100 %) | 4 diff (99.4 %id) | ||
DB271149 | uterus | .g | 56 to 608 | 2 to 557 | capped | 556/556 (100 %) | 3 diff (99.5 %id) | ||
DB273872 | uterus | .i | 57 to 630 | 2 to 575 | R105S | capped | 574/574 (100 %) | 2 diff (99.7 %id) | |
W22212 | eye, retina | .g | 773 to 1235 | 1 to 465 | 465/700 (66 %) | 12 diff (98.3 %id) | |||
W22212 | eye, retina | .g | 773 to 1235 | 1 to 465 | 465/700 (66 %) | 12 diff (98.3 %id) | |||
BP376203 | uterus | .g | 55 to 635 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | |||
BP376353 | uterus | .g | 237 to 806 | 1 to 570 | 570/570 (100 %) | 0 diff (100 %id) | |||
BP378046 | uterus | .i | 332 to 903 | 1 to 572 | 572/572 (100 %) | 0 diff (100 %id) | |||
BP378302 | uterus | .i | 618 to 1197 | 1 to 580 | 580/580 (100 %) | 1 diff (99.9 %id) |